NVIDIA CORP, 10-K filed on 2/24/2023
Annual Report
v3.22.4
Cover Page - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Jan. 29, 2023
Feb. 17, 2023
Jul. 29, 2022
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Jan. 29, 2023    
Current Fiscal Year End Date --01-29    
Document Transition Report false    
Entity File Number 0-23985    
Entity Registrant Name NVIDIA CORP    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 94-3177549    
Entity Address, Address Line One 2788 San Tomas Expressway    
Entity Address, City or Town Santa Clara    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 95051    
City Area Code 408    
Local Phone Number 486-2000    
Title of 12(b) Security Common Stock, $0.001 par value per share    
Trading Symbol NVDA    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Entity Shell Company false    
Entity Public Float     $ 434,370
Entity Common Stock, Shares Outstanding   2,470  
Documents Incorporated by Reference Portions of the registrant's Proxy Statement for its 2023 Annual Meeting of Shareholders to be filed with the Securities and Exchange Commission pursuant to Regulation 14A not later than 120 days after the end of the fiscal year covered by this Annual Report on Form 10-K are incorporated by reference into Part III, Items 10-14 of this Annual Report on Form 10-K.    
Entity Central Index Key 0001045810    
Document Fiscal Year Focus 2023    
Document Fiscal Period Focus FY    
Amendment Flag false    
v3.22.4
Audit Information
12 Months Ended
Jan. 29, 2023
Audit Information [Abstract]  
Auditor Firm ID 238
Auditor Name PricewaterhouseCoopers LLP
Auditor Location San Jose, California
v3.22.4
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Jan. 29, 2023
Jan. 30, 2022
Jan. 31, 2021
Income Statement [Abstract]      
Revenue $ 26,974 $ 26,914 $ 16,675
Cost of revenue 11,618 9,439 6,279
Gross profit 15,356 17,475 10,396
Operating expenses      
Research and development 7,339 5,268 3,924
Sales, general and administrative 2,440 2,166 1,940
Acquisition termination cost 1,353 0 0
Total operating expenses 11,132 7,434 5,864
Income from operations 4,224 10,041 4,532
Interest income 267 29 57
Interest expense (262) (236) (184)
Other, net (48) 107 4
Other income (expense), net (43) (100) (123)
Income before income tax 4,181 9,941 4,409
Income tax expense (benefit) (187) 189 77
Net income $ 4,368 $ 9,752 $ 4,332
Net income per share:      
Basic (in USD per share) $ 1.76 $ 3.91 $ 1.76
Diluted (in USD per share) $ 1.74 $ 3.85 $ 1.73
Weighted average shares used in per share computation:      
Basic (in shares) 2,487 2,496 2,467
Diluted (in shares) 2,507 2,535 2,510
v3.22.4
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Millions
12 Months Ended
Jan. 29, 2023
Jan. 30, 2022
Jan. 31, 2021
Statement of Comprehensive Income [Abstract]      
Net income $ 4,368 $ 9,752 $ 4,332
Available-for-sale debt securities:      
Net unrealized gain (loss) (31) (16) 2
Reclassification adjustments for net realized gain (loss) included in net income 1 0 (2)
Net change in unrealized loss (30) (16) 0
Cash flow hedges:      
Net unrealized gain (loss) 47 (43) 9
Reclassification adjustments for net realized gain (loss) included in net income (49) 29 9
Net change in unrealized gain (loss) (2) (14) 18
Other comprehensive income (loss), net of tax (32) (30) 18
Total comprehensive income $ 4,336 $ 9,722 $ 4,350
v3.22.4
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Jan. 29, 2023
Jan. 30, 2022
Current assets:    
Cash and cash equivalents $ 3,389 $ 1,990
Marketable securities 9,907 19,218
Accounts receivable, net 3,827 4,650
Inventories 5,159 2,605
Prepaid expenses and other current assets 791 366
Total current assets 23,073 28,829
Property and equipment, net 3,807 2,778
Operating lease assets 1,038 829
Goodwill 4,372 4,349
Intangible assets, net 1,676 2,339
Deferred income tax assets 3,396 1,222
Other assets 3,820 3,841
Total assets 41,182 44,187
Current liabilities:    
Accounts payable 1,193 1,783
Accrued and other current liabilities 4,120 2,552
Short-term debt 1,250 0
Total current liabilities 6,563 4,335
Long-term debt 9,703 10,946
Long-term operating lease liabilities 902 741
Other long-term liabilities 1,913 1,553
Total liabilities 19,081 17,575
Commitments and contingencies - see Note 13
Shareholders’ equity:    
Preferred stock, $0.001 par value; 2 shares authorized; none issued 0 0
Common stock, $0.001 par value; 8,000 shares authorized; 2,466 shares issued and outstanding as of January 29, 2023; 2,506 shares issued and outstanding as of January 30, 2022 2 3
Additional paid-in capital 11,971 10,385
Accumulated other comprehensive loss (43) (11)
Retained earnings 10,171 16,235
Total shareholders' equity 22,101 26,612
Total liabilities and shareholders' equity $ 41,182 $ 44,187
v3.22.4
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
shares in Millions
Jan. 29, 2023
Jan. 30, 2022
Statement of Financial Position [Abstract]    
Preferred stock, par value (in USD per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (in shares) 2 2
Preferred stock, shares issued (in shares) 0 0
Common stock, par value (in USD per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 8,000 8,000
Common stock, shares issued (in shares) 2,466 2,506
Common stock, shares outstanding (in shares) 2,466 2,506
v3.22.4
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Common Stock Outstanding
Additional Paid-in Capital
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Beginning balance, common stock outstanding (in shares) at Jan. 26, 2020   2,450        
Beginning balances, shareholders' equity at Jan. 26, 2020 $ 12,204 $ 3 $ 7,043 $ (9,814) $ 1 $ 14,971
Increase (Decrease) in Shareholders' Equity            
Net income 4,332         4,332
Other comprehensive income (loss) 18       18  
Issuance of common stock from stock plans (in shares)   40        
Issuance of common stock from stock plans 194   194      
Tax withholding related to vesting of restricted stock units (in shares)   (11)        
Tax withholding related to vesting of restricted stock units (942)     (942)    
Cash dividends declared and paid (395)         (395)
Fair value of partially vested equity awards assumed in connection with acquisitions 86   86      
Stock-based compensation 1,396   1,396      
Ending balance, common stock outstanding (in shares) at Jan. 31, 2021   2,479        
Ending balances, shareholders' equity at Jan. 31, 2021 16,893 $ 3 8,719 (10,756) 19 18,908
Increase (Decrease) in Shareholders' Equity            
Net income 9,752         9,752
Other comprehensive income (loss) (30)       (30)  
Issuance of common stock from stock plans (in shares)   35        
Issuance of common stock from stock plans 281   281      
Tax withholding related to vesting of restricted stock units (in shares)   (8)        
Tax withholding related to vesting of restricted stock units (1,904)   (614) (1,290)    
Cash dividends declared and paid (399)         (399)
Fair value of partially vested equity awards assumed in connection with acquisitions 18   18      
Stock-based compensation 2,001   2,001      
Retirement of Treasury Stock $ 0   (20) 12,046   (12,026)
Ending balance, common stock outstanding (in shares) at Jan. 30, 2022 2,506 2,506        
Ending balances, shareholders' equity at Jan. 30, 2022 $ 26,612 $ 3 10,385 0 (11) 16,235
Increase (Decrease) in Shareholders' Equity            
Net income 4,368         4,368
Other comprehensive income (loss) (32)       (32)  
Issuance of common stock from stock plans (in shares)   31        
Issuance of common stock from stock plans 355   355      
Tax withholding related to vesting of restricted stock units (in shares)   (8)        
Tax withholding related to vesting of restricted stock units $ (1,475)   (1,475)      
Share repurchase (in shares) (63) (63)        
Share repurchase $ (10,039) $ (1) (4)     (10,034)
Cash dividends declared and paid (398)         (398)
Stock-based compensation $ 2,710   2,710      
Ending balance, common stock outstanding (in shares) at Jan. 29, 2023 2,466 2,466        
Ending balances, shareholders' equity at Jan. 29, 2023 $ 22,101 $ 2 $ 11,971 $ 0 $ (43) $ 10,171
v3.22.4
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Parenthetical) - $ / shares
12 Months Ended
Jan. 29, 2023
Jan. 30, 2022
Jan. 31, 2021
Statement of Stockholders' Equity [Abstract]      
Cash dividends declared and paid (USD per common share) $ 0.16 $ 0.16  
Cash dividends declared and paid (USD per common share) $ 0.16 $ 0.16 $ 0.16
v3.22.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
12 Months Ended
Jan. 29, 2023
Jan. 30, 2022
Jan. 31, 2021
Cash flows from operating activities:      
Net income $ 4,368 $ 9,752 $ 4,332
Adjustments to reconcile net income to net cash provided by operating activities:      
Stock-based compensation expense 2,709 2,004 1,397
Depreciation and amortization 1,544 1,174 1,098
Acquisition termination cost 1,353 0 0
Losses (gains) on investments in non-affiliates, net 45 (100) 0
Deferred income taxes (2,164) (406) (282)
Other (7) 47 (20)
Changes in operating assets and liabilities, net of acquisitions:      
Accounts receivable 822 (2,215) (550)
Inventories (2,554) (774) (524)
Prepaid expenses and other assets (1,517) (1,715) (394)
Accounts payable (551) 568 312
Accrued and other current liabilities 1,341 581 290
Other long-term liabilities 252 192 163
Net cash provided by operating activities 5,641 9,108 5,822
Cash flows from investing activities:      
Proceeds from maturities of marketable securities 19,425 15,197 8,792
Proceeds from sales of marketable securities 1,806 1,023 527
Purchases of marketable securities (11,897) (24,787) (19,308)
Purchases related to property and equipment and intangible assets (1,833) (976) (1,128)
Acquisitions, net of cash acquired (49) (263) (8,524)
Investments and other, net (77) (24) (34)
Net cash provided by (used in) investing activities 7,375 (9,830) (19,675)
Cash flows from financing activities:      
Proceeds related to employee stock plans 355 281 194
Payments related to repurchases of common stock (10,039) 0 0
Payments related to tax on restricted stock units (1,475) (1,904) (942)
Dividends paid (398) (399) (395)
Principal payments on property and equipment (58) (83) (17)
Issuance of debt, net of issuance costs 0 4,977 4,968
Repayment of debt 0 (1,000) 0
Other (2) (7) (4)
Net cash provided by (used in) financing activities (11,617) 1,865 3,804
Change in cash and cash equivalents 1,399 1,143 (10,049)
Cash and cash equivalents at beginning of period 1,990 847 10,896
Cash and cash equivalents at end of period 3,389 1,990 847
Supplemental disclosures of cash flow information:      
Cash paid for income taxes, net 1,404 396 249
Cash paid for interest $ 254 $ 246 $ 138
v3.22.4
Organization and Summary of Significant Accounting Policies
12 Months Ended
Jan. 29, 2023
Accounting Policies [Abstract]  
Organization and Summary of Significant Accounting Policies Organization and Summary of Significant Accounting Policies
Our Company
Headquartered in Santa Clara, California, NVIDIA was incorporated in California in April 1993 and reincorporated in Delaware in April 1998.
All references to “NVIDIA,” “we,” “us,” “our” or the “Company” mean NVIDIA Corporation and its subsidiaries.
Fiscal Year
We operate on a 52- or 53-week year, ending on the last Sunday in January. Fiscal years 2023 and 2022 were both 52-week years. Fiscal year 2021 was a 53-week year.
Reclassifications
Certain prior fiscal year balances have been reclassified to conform to the current fiscal year presentation.
Prior period intangible asset gross carrying amount and accumulated amortization in Note 7 have been adjusted to write off immaterial fully amortized intangible assets as of January 30, 2022.
Principles of Consolidation
Our consolidated financial statements include the accounts of NVIDIA Corporation and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from our estimates. On an on-going basis, we evaluate our estimates, including those related to revenue recognition, cash equivalents and marketable securities, accounts receivable, inventories, income taxes, goodwill, stock-based compensation, litigation, investigation and settlement costs, restructuring and other charges, and other contingencies. The inputs into our judgments and estimates consider the economic implications of COVID-19. These estimates are based on historical facts and various other assumptions that we believe are reasonable.
In February 2023, we completed an assessment of the useful lives of our property, plant, and equipment. Based on advances in technology and usage rate, we increased the estimated useful life of a majority of the server, storage, and network equipment from three to a range of four to five years, and assembly and test equipment from five to seven years. This change in accounting estimate became effective at the beginning of fiscal year 2024. Based on the carrying amounts of a majority of our server, storage, network, and assembly and test equipment, net in use as of the end of fiscal year 2023, it is estimated this change will increase our fiscal year 2024 operating income by $133 million as a result of the reduction in depreciation expense.
Revenue Recognition
We derive our revenue from product sales, including hardware and systems, license and development arrangements, software licensing, and cloud services. We determine revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract (where revenue is allocated on a relative standalone selling price basis by maximizing the use of observable inputs to determine the standalone selling price for each performance obligation); and (5) recognition of revenue when, or as, we satisfy a performance obligation.
Product Sales Revenue
Revenue from product sales is recognized upon transfer of control of products to customers in an amount that reflects the consideration we expect to receive in exchange for those products. Certain products are
sold with support or an extended warranty for the incorporated system, hardware, and/or software. Support and extended warranty revenue are recognized ratably over the service period, or as services are performed. Revenue is recognized net of allowances for returns, customer programs and any taxes collected from customers.
For products sold with a right of return, we record a reduction to revenue by establishing a sales return allowance for estimated product returns at the time revenue is recognized, based primarily on historical return rates. However, if product returns for a fiscal period are anticipated to exceed historical return rates, we may determine that additional sales return allowances are required to properly reflect our estimated exposure for product returns.
Our customer programs involve rebates, which are designed to serve as sales incentives to resellers of our products in various target markets, and marketing development funds, or MDFs, which represent monies paid to our partners that are earmarked for market segment development and are designed to support our partners’ activities while also promoting NVIDIA products. We account for customer programs as a reduction to revenue and accrue for potential rebates and MDFs based on the amount we expect to be claimed by customers.
License and Development Arrangements
Our license and development arrangements with customers typically require significant customization of our IP components. As a result, we recognize the revenue from the license and the revenue from the development services as a single performance obligation over the period in which the development services are performed. We measure progress to completion based on actual cost incurred to date as a percentage of the estimated total cost required to complete each project. If a loss on an arrangement becomes probable during a period, we record a provision for such loss in that period.
Software Licensing
Our software licenses provide our customers with a right to use the software when it is made available to the customer. Customers may purchase either perpetual licenses or subscriptions to licenses, which differ mainly in the duration over which the customer benefits from the software. Software licenses are frequently sold along with the right to receive, on a when-and-if available basis, future unspecified software updates and upgrades. Revenue from software licenses is recognized up front when the software is made available to the customer. Software support revenue is recognized ratably over the service period, or as services are performed.
Cloud Services
Cloud services, which allow customers to use hosted software and hardware infrastructure without taking possession of the software or hardware, are provided on a subscription basis or a combination of subscription plus usage. Revenue related to subscription-based cloud services is recognized ratably over the contract period. Revenue related to cloud services based on usage is recognized as usage occurs.
Product Warranties
We generally offer a limited warranty to end-users that ranges from one to three years for products in order to repair or replace products for any manufacturing defects or hardware component failures. Cost of revenue includes the estimated cost of product warranties that are calculated at the point of revenue recognition. Under limited circumstances, we may offer an extended limited warranty to customers for certain products. We also accrue for known warranty and indemnification issues if a loss is probable and can be reasonably estimated.
Stock-based Compensation
We use the closing trading price of our common stock on the date of grant, minus a dividend yield discount, as the fair value of awards of restricted stock units, or RSUs, and performance stock units that are based on our corporate financial performance targets, or PSUs. We use a Monte Carlo simulation on the date of grant to estimate the fair value of performance stock units that are based on market conditions, or market-based PSUs. The compensation expense for RSUs and market-based PSUs is recognized using a straight-line
attribution method over the requisite employee service period while compensation expense for PSUs is recognized using an accelerated amortization model. We estimate the fair value of shares to be issued under our employee stock purchase plan, or ESPP, using the Black-Scholes model at the commencement of an offering period in March and September of each year. Stock-based compensation for our ESPP is expensed using an accelerated amortization model. Additionally, we estimate forfeitures at least annually based on historical experience and revise the estimates of forfeiture in subsequent periods if actual forfeitures differ from those estimates.
Litigation, Investigation and Settlement Costs
We currently, are, and will likely continue to be subject to claims, litigation, and other actions, including potential regulatory proceedings, involving patent and other intellectual property matters, taxes, labor and employment, competition and antitrust, commercial disputes, goods and services offered by us and by third parties, and other matters. There are many uncertainties associated with any litigation or investigation, and we cannot be certain that these actions or other third-party claims against us will be resolved without litigation, fines and/or substantial settlement payments or judgments. If information becomes available that causes us to determine that a loss in any of our pending litigation, investigations or settlements is probable, and we can reasonably estimate the loss associated with such events, we will record the loss in accordance with U.S. GAAP. However, the actual liability in any such litigation or investigation may be materially different from our estimates, which could require us to record additional costs.
Foreign Currency Remeasurement
We use the United States dollar as our functional currency for our subsidiaries. Foreign currency monetary assets and liabilities are remeasured into United States dollars at end-of-period exchange rates. Non-monetary assets and liabilities such as property and equipment and equity are remeasured at historical exchange rates. Revenue and expenses are remeasured at exchange rates in effect during each period, except for those expenses related to non-monetary balance sheet amounts, which are remeasured at historical exchange rates. Gains or losses from foreign currency remeasurement are included in earnings in our Consolidated Statements of Income and to date have not been significant.
Income Taxes
We recognize federal, state and foreign current tax liabilities or assets based on our estimate of taxes payable or refundable in the current fiscal year by tax jurisdiction. We recognize federal, state and foreign deferred tax assets or liabilities, as appropriate, for our estimate of future tax effects attributable to temporary differences and carryforwards; and we record a valuation allowance to reduce any deferred tax assets by the amount of any tax benefits that, based on available evidence and judgment, are not expected to be realized.
Our calculation of deferred tax assets and liabilities is based on certain estimates and judgments and involves dealing with uncertainties in the application of complex tax laws. Our estimates of deferred tax assets and liabilities may change based, in part, on added certainty or finality to an anticipated outcome, changes in accounting standards or tax laws in the United States, or foreign jurisdictions where we operate, or changes in other facts or circumstances. In addition, we recognize liabilities for potential United States and foreign income tax contingencies based on our estimate of whether, and the extent to which, additional taxes may be due. If we determine that payment of these amounts is unnecessary or if the recorded tax liability is less than our current assessment, we may be required to recognize an income tax benefit or additional income tax expense in our financial statements accordingly.
As of January 29, 2023, we had a valuation allowance of $1.48 billion related to capital loss carryforwards, state, and certain other deferred tax assets that management determined are not likely to be realized due to jurisdictional projections of future taxable income, including capital gains, tax attributes usage limitation by certain jurisdictions, and potential utilization limitations of tax attributes acquired as a result of stock ownership changes. To the extent realization of the deferred tax assets becomes more-likely-than-not, we would recognize such deferred tax assets as an income tax benefit during the period.
We recognize the benefit from a tax position only if it is more-likely-than-not that the position would be sustained upon audit based solely on the technical merits of the tax position. Our policy is to include interest and penalties related to unrecognized tax benefits as a component of income tax expense.
Net Income Per Share
Basic net income per share is computed using the weighted average number of common shares outstanding during the period. Diluted net income per share is computed using the weighted average number of common and potentially dilutive shares outstanding during the period, using the treasury stock method. Under the treasury stock method, the effect of equity awards outstanding is not included in the computation of diluted net income per share for periods when their effect is anti-dilutive.
Cash and Cash Equivalents and Marketable Securities
We consider all highly liquid investments that are readily convertible into cash and have an original maturity of three months or less at the time of purchase to be cash equivalents. Marketable securities consist of highly liquid debt investments with maturities of greater than three months when purchased. We currently classify our investments as current based on the nature of the investments and their availability for use in current operations.
We classify our cash equivalents and marketable securities related to debt securities at the date of acquisition as available-for-sale. These available-for-sale debt securities are reported at fair value with the related unrealized gains and losses included in accumulated other comprehensive income or loss, a component of shareholders’ equity, net of tax. The fair value of interest-bearing debt securities includes accrued interest. Realized gains and losses on the sale of marketable securities are determined using the specific-identification method and recorded in the other income (expense), net, section of our Consolidated Statements of Income.
Available-for-sale debt investments are subject to a periodic impairment review. If the estimated fair value of available-for-sale debt securities is less than its amortized cost basis, we determine if the difference, if any, is caused by expected credit losses and write-down the amortized cost basis of the securities if it is more likely than not we will be required or we intend to sell the securities before recovery of its amortized cost basis. Allowances for credit losses and write-downs are recognized in the other income (expense), net section of our Consolidated Statements of Income.
Fair Value of Financial Instruments
The carrying value of cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate their fair values due to their relatively short maturities as of January 29, 2023 and January 30, 2022. Marketable securities are comprised of available-for-sale securities that are reported at fair value with the related unrealized gains or losses included in accumulated other comprehensive income or loss, a component of shareholders’ equity, net of tax. Fair value of the marketable securities is determined based on quoted market prices. Derivative instruments are recognized as either assets or liabilities and are measured at fair value. The accounting for changes in the fair value of a derivative depends on the intended use of the derivative and the resulting designation. For derivative instruments designated as fair value hedges, the gains or losses are recognized in earnings in the periods of change together with the offsetting losses or gains on the hedged items attributed to the risk being hedged. For derivative instruments designated as cash-flow hedges, the effective portion of the gains or losses on the derivatives is initially reported as a component of other comprehensive income or loss and is subsequently recognized in earnings when the hedged exposure is recognized in earnings. For derivative instruments not designated for hedge accounting, changes in fair value are recognized in earnings.
Concentration of Credit Risk
Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash equivalents, marketable securities, and accounts receivable. Our investment policy requires the purchase of highly-rated fixed income securities, the diversification of investment type and credit exposures, and includes certain limits on our portfolio duration. We perform ongoing credit evaluations of our customers’ financial condition and maintain an allowance for potential credit losses. This allowance consists of an amount
identified for specific customers and an amount based on overall estimated exposure. Our overall estimated exposure excludes amounts covered by credit insurance and letters of credit.
Inventories
Inventory cost is computed on an adjusted standard basis, which approximates actual cost on an average or first-in, first-out basis. Inventory costs consist primarily of the cost of semiconductors, including wafer fabrication, assembly, testing and packaging, manufacturing support costs, including labor and overhead associated with such purchases, final test yield fallout, and shipping costs, as well as the cost of purchased memory products and other component parts. We charge cost of sales for inventory provisions to write-down our inventory to the lower of cost or net realizable value or for obsolete or excess inventory, and for excess product purchase commitments. Most of our inventory provisions relate to excess quantities of products, based on our inventory levels and future product purchase commitments compared to assumptions about future demand and market conditions. Once inventory has been written-off or written-down, it creates a new cost basis for the inventory that is not subsequently written-up. We record a liability for noncancelable purchase commitments with suppliers for quantities in excess of our future demand forecasts consistent with our valuation of obsolete or excess inventory.
Property and Equipment
Property and equipment are stated at cost. Depreciation of property and equipment is computed using the straight-line method based on the estimated useful lives of the assets, generally three to five years. Once an asset is identified for retirement or disposition, the related cost and accumulated depreciation or amortization are removed, and a gain or loss is recorded. The estimated useful lives of our buildings are up to thirty years. Depreciation expense includes the amortization of assets recorded under finance leases. Leasehold improvements and assets recorded under finance leases are amortized over the shorter of the expected lease term or the estimated useful life of the asset.
Leases
We determine if an arrangement is or contains a lease at inception. Operating leases with lease terms of more than 12 months are included in operating lease assets, accrued and other current liabilities, and long-term operating lease liabilities on our consolidated balance sheet. Operating lease assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments over the lease term.
Operating lease assets and liabilities are recognized based on the present value of the remaining lease payments discounted using our incremental borrowing rate. Operating lease assets also include initial direct costs incurred and prepaid lease payments, minus any lease incentives. Our lease terms include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense is recognized on a straight-line basis over the lease term.
We combine the lease and non-lease components in determining the operating lease assets and liabilities.
Goodwill
Goodwill is subject to our annual impairment test during the fourth quarter of our fiscal year, or earlier if indicators of potential impairment exist. For the purposes of completing our impairment test, we perform either a qualitative or a quantitative analysis on a reporting unit basis. 
Qualitative factors include industry and market considerations, overall financial performance, and other relevant events and factors affecting the reporting units.
The quantitative impairment test considers both the income approach and the market approach to estimate a reporting unit’s fair value. The income and market valuation approaches consider factors that include, but are not limited to, prospective financial information, growth rates, residual values, discount rates and comparable multiples from publicly traded companies in our industry and require us to make certain assumptions and estimates regarding industry economic factors and the future profitability of our business. 
Intangible Assets and Other Long-Lived Assets
Intangible assets primarily represent acquired intangible assets including developed technology, in-process research and development, or IPR&D, and customer relationships, as well as rights acquired under technology licenses, patents, and acquired IP. We currently amortize our intangible assets with finite lives over periods ranging from one to twenty years using a method that reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up or, if that pattern cannot be reliably determined, using a straight-line amortization method. We initially capitalize the fair value of IPR&D as an intangible asset with an indefinite life. When IPR&D projects are completed, we reclassify the IPR&D as an amortizable purchased intangible asset and amortize over the asset’s estimated useful life.
Long-lived assets, such as property and equipment and intangible assets subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. Recoverability of assets or asset groups to be held and used is measured by a comparison of the carrying amount of an asset or asset group to estimated undiscounted future cash flows expected to be generated by the asset or asset group. If the carrying amount of an asset or asset group exceeds its estimated future cash flows, an impairment charge is recognized for the amount by which the carrying amount of the asset or asset group exceeds the estimated fair value of the asset or asset group. Fair value is determined based on the estimated discounted future cash flows expected to be generated by the asset or asset group. Assets and liabilities to be disposed of would be separately presented in the Consolidated Balance Sheet and the assets would be reported at the lower of the carrying amount or fair value less costs to sell, and would no longer be depreciated.
Business Combination
We allocate the fair value of the purchase price of an acquisition to the tangible assets acquired, liabilities assumed, and intangible assets acquired, including IPR&D, based on their estimated fair values. The excess of the fair value of the purchase price over the fair values of these net tangible and intangible assets acquired is recorded as goodwill. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but our estimates and assumptions are inherently uncertain and subject to refinement. The estimates and assumptions used in valuing intangible assets include, but are not limited to, the amount and timing of projected future cash flows, discount rate used to determine the present value of these cash flows and asset lives. These estimates are inherently uncertain and, therefore, actual results may differ from the estimates made. As a result, during the measurement period of up to one year from the acquisition date, we may record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the fair value of the purchase price of an acquisition, whichever comes first, any subsequent adjustments are recorded to our Consolidated Statements of Income.
Acquisition-related expenses are recognized separately from the business combination and expensed as incurred.
Investment in Non-Affiliated Entities
Non-marketable equity investments in privately-held companies are recorded at fair value on a non-recurring basis only if an impairment or observable price adjustment occurs in the period with changes in fair value recorded through net income. These investments are valued using observable and unobservable inputs or data in an inactive market and the valuation requires our judgment due to the absence of market prices and inherent lack of liquidity. The estimated fair value is based on quantitative and qualitative factors including subsequent financing activities by the investee.
Marketable equity investments in publicly-held companies are recorded at fair value with the related unrealized and realized gains and losses recognized in other income (expense), net.
v3.22.4
Business Combination
12 Months Ended
Jan. 29, 2023
Business Combination and Asset Acquisition [Abstract]  
Business Combination Business Combination
Termination of the Arm Share Purchase Agreement
In February 2022, NVIDIA and SoftBank announced the termination of the Share Purchase Agreement whereby NVIDIA would have acquired Arm from SoftBank. The parties agreed to terminate due to significant
regulatory challenges preventing the completion of the transaction. We recorded an acquisition termination cost of $1.35 billion in fiscal year 2023 reflecting the write-off of the prepayment provided at signing.
Acquisition of Mellanox Technologies, Ltd.
In April 2020, we completed the acquisition of all outstanding shares of Mellanox for a total purchase consideration of $7.13 billion.
Purchase Price Allocation
The aggregate purchase consideration has been allocated as follows (in millions):
Purchase Price
Cash paid for outstanding Mellanox ordinary shares (1)$7,033 
Cash for Mellanox equity awards (2)16 
Total cash consideration7,049 
Fair value of Mellanox equity awards assumed by NVIDIA (3)85 
Total purchase consideration$7,134 
Allocation
Cash and cash equivalents$115 
Marketable securities699 
Accounts receivable, net216 
Inventories320 
Prepaid expenses and other assets179 
Property and equipment, net144 
Goodwill3,431 
Intangible assets2,970 
Accounts payable(136)
Accrued and other current liabilities(236)
Income tax liability(191)
Deferred income tax liability(258)
Other long-term liabilities(119)
$7,134 

(1)    Represents the cash consideration of $125.00 per share paid to Mellanox shareholders for approximately 56 million shares of outstanding Mellanox ordinary shares.
(2)    Represents the cash consideration for the settlement of approximately 249 thousand Mellanox stock options held by employees and non-employee directors of Mellanox.
(3)    Represents the fair value of Mellanox’s stock-based compensation awards attributable to pre-combination services.

We allocated the purchase price to tangible and identified intangible assets acquired and liabilities assumed based on the estimated fair values.
The goodwill is primarily attributable to the planned growth in the combined business of NVIDIA and Mellanox. Goodwill is not amortized to earnings, but instead is reviewed for impairment at least annually, absent any interim indicators of impairment. Goodwill recognized in the acquisition is not expected to be deductible for foreign tax purposes. Goodwill arising from the Mellanox acquisition has been allocated to the Compute and Networking segment. Refer to Note 17 – Segment Information for further details on segments.
The operating results of Mellanox have been included in our consolidated financial statements for fiscal year 2021 since the acquisition date of April 27, 2020. Revenue attributable to Mellanox was approximately 10% for fiscal year 2021. There is not a practical way to determine net income attributable to Mellanox due to
integration. Acquisition-related costs attributable to Mellanox of $28 million were included in selling, general and administrative expense for fiscal year 2021.
Intangible Assets
The estimated fair value and useful life of the acquired intangible assets at the time of the acquisition are as follows:
Fair ValueUseful Lives
(In millions)
Developed technology (1)$1,640 5 years
Customer relationships (2)440 3 years
Order backlog (3)190 Based on actual shipments
Trade names (4)70 5 years
Total identified finite-lived intangible assets2,340 
IPR&D (5)630 N/A
Total identified intangible assets$2,970 

(1)    The fair value of developed technology was identified using the Multi-Period Excess Earnings Method.
(2)    Customer relationships represent the fair value of the existing relationships using the With and Without Method.
(3)    Order backlog represents primarily the fair value of purchase arrangements with customers using the Multi-Period Excess Earnings Method. The intangible asset was fully amortized as of January 31, 2021.
(4)    Trade names primarily relate to Mellanox trade names and fair value was determined by applying the Relief-from-Royalty Method under the income approach.
(5)    The fair value of IPR&D was determined using the Multi-Period Excess Earnings Method.

The fair value of the finite-lived intangible assets will be amortized over the estimated useful lives based on the pattern in which the economic benefits are expected to be received to cost of revenue and operating expenses.
Mellanox had an IPR&D project associated with the next generation interconnect product that had not yet reached technological feasibility as of the acquisition date. Accordingly, we recorded an indefinite-lived intangible asset of $630 million for the fair value of this project, which was initially not amortized. In fiscal year 2023, we commenced amortization of the IPR&D intangible asset.
Supplemental Unaudited Pro Forma Information
The following unaudited pro forma financial information summarizes the combined results of operations for NVIDIA and Mellanox as if the companies were combined as of the beginning of fiscal year 2020:
Pro Forma
 Year Ended
 January 31, 2021
(In millions)
Revenue$17,104 
Net income$4,757 
The unaudited pro forma information presented above includes adjustments related to amortization of acquired intangible assets, adjustments to stock-based compensation expense, fair value of acquired inventory, and transaction costs. The unaudited pro forma information is for informational purposes only and is not necessarily indicative of our consolidated results of operations of the combined business had the acquisition actually occurred at the beginning of fiscal year 2020 or of the results of our future operations of the combined businesses.
The pro forma results for fiscal year 2021 excluded the inventory step-up expense of $161 million. There were no other material nonrecurring adjustments.
v3.22.4
Leases
12 Months Ended
Jan. 29, 2023
Leases [Abstract]  
Leases Leases
Our lease obligations primarily consist of operating leases for our headquarters complex, domestic and international office facilities, and data center space, with lease periods expiring between fiscal years 2024 and 2035.
Future minimum lease payments under our non-cancelable operating leases as of January 29, 2023, are as follows:
Operating Lease Obligations
 (In millions)
Fiscal Year: 
2024$220 
2025198 
2026180 
2027166 
2028144 
2029 and thereafter323 
Total1,231 
Less imputed interest153 
Present value of net future minimum lease payments1,078 
Less short-term operating lease liabilities176 
Long-term operating lease liabilities$902 
In addition to above, we have operating leases, primarily for our data centers, that are expected to commence within fiscal years 2024 and 2025 with lease terms of 2 to 8 years for $463 million.

Operating lease expense for fiscal years 2023, 2022, and 2021 was $193 million, $168 million, $145 million, respectively. Short-term and variable lease expenses for fiscal years 2023, 2022, and 2021 were not significant.

Other information related to leases was as follows:
Year Ended
January 29, 2023January 30, 2022January 31, 2021
 (In millions)
Supplemental cash flows information 
Operating cash flows used for operating leases$184 $154 $141 
Operating lease assets obtained in exchange for lease obligations$358 $266 $200 

As of January 29, 2023, our operating leases had a weighted average remaining lease term of 6.8 years and a weighted average discount rate of 3.21%. As of January 30, 2022, our operating leases had a weighted average remaining lease term of 7.1 years and a weighted average discount rate of 2.51%.
v3.22.4
Stock-Based Compensation
12 Months Ended
Jan. 29, 2023
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
Our stock-based compensation expense is associated with restricted stock units, or RSUs, performance stock units that are based on our corporate financial performance targets, or PSUs, performance stock units that are based on market conditions, or market-based PSUs, and our ESPP.
Our Consolidated Statements of Income include stock-based compensation expense, net of amounts allocated to inventory, as follows:
 Year Ended
January 29,
2023
January 30,
2022
January 31,
2021
 (In millions)
Cost of revenue$138 $141 $88 
Research and development1,892 1,298 860 
Sales, general and administrative680 565 449 
Total$2,710 $2,004 $1,397 
Stock-based compensation capitalized in inventories was not significant during fiscal years 2023, 2022, and 2021.
The following is a summary of equity awards granted under our equity incentive plans:
Year Ended
January 29,
2023
January 30,
2022
January 31,
2021
(In millions, except per share data)
RSUs, PSUs and Market-based PSUs
Awards granted25 18 36 
Estimated total grant-date fair value$4,505 $3,492 $2,764 
Weighted average grant-date fair value per share$183.72 $190.69 $76.81 
ESPP
Shares purchased
Weighted average price per share$122.54 $56.36 $34.80 
Weighted average grant-date fair value per share$51.87 $23.24 $16.91 
As of January 29, 2023, there was $6.56 billion of aggregate unearned stock-based compensation expense. This amount is expected to be recognized over a weighted average period of 2.6 years for RSUs, PSUs, and market-based PSUs, and 1.0 year for ESPP.
The fair value of shares issued under our ESPP have been estimated with the following assumptions:
 Year Ended
 January 29,
2023
January 30,
2022
January 31,
2021
(Using the Black-Scholes model)
ESPP
Weighted average expected life (in years)
0.1-2.0
0.1-2.0
0.1-2.0
Risk-free interest rate
—%-4.6%
—%-0.5%
0.1%-1.6%
Volatility
43%-72%
20%-58%
26%-89%
Dividend yield
0.1%
0.1%
0.1%-0.3%
For ESPP shares, the expected term represents the average term from the first day of the offering period to the purchase date. The risk-free interest rate assumption used to value ESPP shares is based upon observed interest rates on Treasury bills appropriate for the expected term. Our expected stock price volatility assumption for ESPP is estimated using historical volatility. For awards granted, we use the dividend yield at grant date. Our RSU, PSU, and market-based PSU awards are not eligible for cash dividends prior to vesting; therefore, the fair values of RSUs, PSUs, and market-based PSUs are discounted for the dividend yield.
Additionally, for RSU, PSU, and market-based PSU awards, we estimate forfeitures semi-annually and revise the estimates of forfeiture in subsequent periods if actual forfeitures differ from those estimates. Forfeitures are estimated based on historical experience.
Equity Incentive Program
We grant or have granted stock options, RSUs, PSUs, market-based PSUs, and stock purchase rights under the following equity incentive plans. In addition, in connection with our acquisitions of various companies, we have assumed certain stock-based awards granted under their stock incentive plans and converted them into our RSUs.
Amended and Restated 2007 Equity Incentive Plan
In 2007, our shareholders approved the NVIDIA Corporation 2007 Equity Incentive Plan, as most recently amended and restated, or the 2007 Plan.
The 2007 Plan authorizes the issuance of incentive stock options, non-statutory stock options, restricted stock, restricted stock units, stock appreciation rights, performance stock awards, performance cash awards, and other stock-based awards to employees, directors and consultants. Only our employees may receive incentive stock options. As of January 29, 2023, up to 47 million shares of our common stock could be issued pursuant to stock awards granted under the 2007 Plan, of which 2 million shares were issuable upon the exercise of outstanding stock options. All options are fully vested, the last of which will expire by December 2023 if not exercised. Currently, we grant RSUs, PSUs and market-based PSUs under the 2007 Plan, under which, as of January 29, 2023, there were 160 million shares available for future grants.
Subject to certain exceptions, RSUs granted to employees vest (A) over a four-year period, subject to continued service, with 25% vesting on a pre-determined date that is close to the anniversary of the date of grant and 6.25% vesting quarterly thereafter, (B) over a three-year period, subject to continued service, with 40% vesting on a pre-determined date that is close to the anniversary of the date of grant and 7.5% vesting quarterly thereafter, or (C) over a four-year period, subject to continued service, with 6.25% vesting quarterly. PSUs vest over a four-year period, subject to continued service, with 25% vesting on a pre-determined date that is close to the anniversary of the date of grant and 6.25% vesting quarterly thereafter. Market-based PSUs vest 100% on approximately the three-year anniversary of the date of grant. However, the number of shares subject to both PSUs and market-based PSUs that are eligible to vest is generally determined by the Compensation Committee based on achievement of pre-determined criteria.
Amended and Restated 2012 Employee Stock Purchase Plan
In 2012, our shareholders approved the NVIDIA Corporation 2012 Employee Stock Purchase Plan, as most recently amended and restated, or the 2012 Plan.
Employees who participate in the 2012 Plan may have up to 15% of their earnings withheld to purchase shares of common stock. The Board may decrease this percentage at its discretion. Each offering period is approximately 24 months, which is generally divided into four purchase periods of six months. The price of common stock purchased under our 2012 Plan will be equal to 85% of the lower of the fair market value of the common stock on the commencement date of each offering period or the fair market value of the common stock on each purchase date within the offering. As of January 29, 2023, we had 230 million shares reserved for future issuance under the 2012 Plan.
Equity Award Activity
The following is a summary of our equity award transactions under our equity incentive plans: 
RSUs, PSUs and Market-based PSUs Outstanding
 Number of SharesWeighted Average Grant-Date Fair Value
(In millions, except per share data)
Balances, January 30, 202246 $114.19 
Granted25 $183.72 
Vested restricted stock(24)$100.06 
Canceled and forfeited(2)$141.17 
Balances, January 29, 202345 $158.45 
Vested and expected to vest after January 29, 202345 $158.35 

As of January 29, 2023 and January 30, 2022, there were 160 million and 131 million shares, respectively, of common stock available for future grants under our equity incentive plans. 
As of January 29, 2023, the total intrinsic value of options currently exercisable and outstanding was $410 million, with an average exercise price of $3.79 per share and an average remaining term of 0.5 years. The total intrinsic value of options exercised was $642 million, $741 million, and $521 million for fiscal years 2023, 2022, and 2021, respectively. Upon the exercise of an option, we issue a new share of stock.
The total fair value of RSUs and PSUs, as of their respective vesting dates, during the years ended January 29, 2023, January 30, 2022, and January 31, 2021, was $4.27 billion, $5.56 billion, and $2.67 billion, respectively.
v3.22.4
Net Income Per Share
12 Months Ended
Jan. 29, 2023
Earnings Per Share [Abstract]  
Net Income Per Share Net Income Per Share
The following is a reconciliation of the denominator of the basic and diluted net income per share computations for the periods presented:
 Year Ended
 January 29,
2023
January 30,
2022
January 31,
2021
 (In millions, except per share data)
Numerator:   
Net income$4,368 $9,752 $4,332 
Denominator:   
Basic weighted average shares2,487 2,496 2,467 
Dilutive impact of outstanding equity awards20 39 43 
Diluted weighted average shares2,507 2,535 2,510 
Net income per share:   
Basic (1)$1.76 $3.91 $1.76 
Diluted (2)$1.74 $3.85 $1.73 
Equity awards excluded from diluted net income per share because their effect would have been anti-dilutive
40 21 12 
(1)    Calculated as net income divided by basic weighted average shares.
(2)    Calculated as net income divided by diluted weighted average shares.
v3.22.4
Goodwill
12 Months Ended
Jan. 29, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill GoodwillAs of January 29, 2023, the total carrying amount of goodwill was $4.37 billion, consisting of goodwill balances allocated to our Compute & Networking and Graphics reporting units of $4.00 billion and $370 million, respectively. As of January 30, 2022, the total carrying amount of goodwill was $4.35 billion, consisting of goodwill balances allocated to our Compute & Networking and Graphics reporting units of $3.99 billion and $361 million, respectively. Goodwill increased by $23 million in fiscal year 2023 from acquisitions. We assigned $14 million of the increase in goodwill to our Compute & Networking segment and assigned $9 million of the increase to our Graphics segment. During the fourth quarters of fiscal years 2023, 2022, and 2021, we completed our annual qualitative impairment tests and concluded that goodwill was not impaired in any of these years.
v3.22.4
Amortizable Intangible Assets
12 Months Ended
Jan. 29, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Amortizable Intangible Assets Amortizable Intangible Assets
The components of our amortizable intangible assets are as follows:
 January 29, 2023January 30, 2022
 
Gross
Carrying
Amount
Accumulated
Amortization
Net 
Carrying
Amount
Gross
Carrying
Amount
Accumulated
Amortization
Net 
Carrying
Amount
 (In millions)
Acquisition-related intangible assets (1)$3,093 $(1,614)$1,479 $3,061 $(947)$2,114 
Patents and licensed technology446 (249)197 446 (221)225 
Total intangible assets$3,539 $(1,863)$1,676 $3,507 $(1,168)$2,339 
(1)    During the first quarter of fiscal year 2023, we commenced amortization of a $630 million in-process research and development intangible asset related to our acquisition of Mellanox.
Amortization expense associated with intangible assets for fiscal years 2023, 2022, and 2021 was $699 million, $563 million, and $612 million, respectively. Future amortization expense related to the net carrying amount of intangible assets as of January 29, 2023 is estimated to be $602 million in fiscal year 2024, $541 million in fiscal year 2025, $247 million in fiscal year 2026, $142 million in fiscal year 2027, $35 million in fiscal year 2028, and $109 million in fiscal year 2029 and thereafter.
v3.22.4
Cash Equivalents and Marketable Securities
12 Months Ended
Jan. 29, 2023
Investments, Debt and Equity Securities [Abstract]  
Cash Equivalents and Marketable Securities Cash Equivalents and Marketable Securities
Our cash equivalents and marketable securities related to debt securities are classified as “available-for-sale” debt securities.
The following is a summary of cash equivalents and marketable securities as of January 29, 2023 and January 30, 2022:
 January 29, 2023
Amortized
Cost
Unrealized
Gain
Unrealized
Loss
Estimated
Fair Value
Reported as
 Cash EquivalentsMarketable Securities
 (In millions)
Corporate debt securities$4,809 $— $(12)$4,797 $1,087 $3,710 
Debt securities issued by the United States Treasury4,185 (44)4,142 — 4,142 
Debt securities issued by United States government agencies1,836 — (2)1,834 50 1,784 
Money market funds1,777 — — 1,777 1,777 — 
Certificates of deposit365 — — 365 134 231 
Foreign government bonds140 — — 140 100 40 
Total$13,112 $$(58)$13,055 $3,148 $9,907 
 January 30, 2022
Amortized
Cost
Unrealized
Gain
Unrealized
Loss
Estimated
Fair Value
Reported as
 Cash EquivalentsMarketable Securities
 (In millions)
Corporate debt securities$9,977 $— $(3)$9,974 $1,102 $8,872 
Debt securities issued by the United States Treasury7,314 — (14)7,300 — 7,300 
Debt securities issued by United States government agencies1,612 — — 1,612 256 1,356 
Certificates of deposit1,561 — — 1,561 21 1,540 
Money market funds316 — — 316 316 — 
Foreign government bonds150 — — 150 — 150 
Total$20,930 $— $(17)$20,913 $1,695 $19,218 
The following tables provide the breakdown of unrealized losses as of January 29, 2023 and January 30, 2022, aggregated by investment category and length of time that individual securities have been in a continuous loss position:
January 29, 2023
 Less than 12 Months12 Months or GreaterTotal
 Estimated Fair ValueGross Unrealized LossEstimated Fair ValueGross Unrealized LossEstimated Fair ValueGross Unrealized Loss
 (In millions)
Debt securities issued by the United States Treasury$2,444 $(21)$1,172 $(23)$3,616 $(44)
Corporate debt securities1,188 (7)696 (5)1,884 (12)
Debt securities issued by United States government agencies1,307 (2)— — 1,307 (2)
Total$4,939 $(30)$1,868 $(28)$6,807 $(58)
January 30, 2022
 Less than 12 Months12 Months or GreaterTotal
 Estimated Fair ValueGross Unrealized LossEstimated Fair ValueGross Unrealized LossEstimated Fair ValueGross Unrealized Loss
 (In millions)
Debt securities issued by the United States Treasury$5,292 $(14)$— $— $5,292 $(14)
Corporate debt securities2,445 (3)19 — 2,464 (3)
Total$7,737 $(17)$19 $— $7,756 $(17)
The gross unrealized losses are related to fixed income securities, driven primarily by changes in interest rates. Net realized gains and losses were not significant for all periods presented.
The amortized cost and estimated fair value of cash equivalents and marketable securities as of January 29, 2023 and January 30, 2022 are shown below by contractual maturity.
 January 29, 2023January 30, 2022
 Amortized
Cost
Estimated
Fair Value
Amortized
Cost
Estimated
Fair Value
 (In millions)
Less than one year$9,738 $9,708 $16,346 $16,343 
Due in 1 - 5 years3,374 3,347 4,584 4,570 
Total$13,112 $13,055 $20,930 $20,913 
v3.22.4
Fair Value of Financial Assets and Liabilities
12 Months Ended
Jan. 29, 2023
Fair Value Disclosures [Abstract]  
Fair Value of Financial Assets and Liabilities Fair Value of Financial Assets and LiabilitiesThe fair values of our financial assets and liabilities are determined using quoted market prices of identical assets or quoted market prices of similar assets from active markets. We review fair value hierarchy classification on a quarterly basis.
Fair Value at
Pricing CategoryJanuary 29, 2023January 30, 2022
(In millions)
Assets
Cash equivalents and marketable securities:
Money market fundsLevel 1$1,777 $316 
Corporate debt securitiesLevel 2$4,797 $9,974 
Debt securities issued by the United States TreasuryLevel 2$4,142 $7,300 
Debt securities issued by United States government agenciesLevel 2$1,834 $1,612 
Certificates of depositLevel 2$365 $1,561 
Foreign government bondsLevel 2$140 $150 
Other assets (Investment in non-affiliated entities):
Publicly-held equity securities (1)Level 1$11 $58 
Privately-held equity securitiesLevel 3$288 $208 
Liabilities (2)
0.309% Notes Due 2023
Level 2$1,230 $1,236 
0.584% Notes Due 2024
Level 2$1,185 $1,224 
3.20% Notes Due 2026
Level 2$966 $1,055 
1.55% Notes Due 2028
Level 2$1,099 $1,200 
2.85% Notes Due 2030
Level 2$1,364 $1,542 
2.00% Notes Due 2031
Level 2$1,044 $1,200 
3.50% Notes Due 2040
Level 2$870 $1,066 
3.50% Notes Due 2050
Level 2$1,637 $2,147 
3.70% Notes Due 2060
Level 2$410 $551 
(1)    Unrealized losses of $61 million from investments in publicly-traded equity securities were recorded in other income (expense), net, in fiscal year 2023. Unrealized gains of $48 million from an investment in a publicly-traded equity security were recorded in other income (expense), net, in fiscal year 2022.
(2)    These liabilities are carried on our Consolidated Balance Sheets at their original issuance value, net of unamortized debt discount and issuance costs.
v3.22.4
Balance Sheet Components
12 Months Ended
Jan. 29, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheet Components Balance Sheet Components
Certain balance sheet components are as follows:
 January 29,
2023
January 30,
2022
(In millions)
Inventories (1):
Raw materials$2,430 $791 
Work in-process466 692 
Finished goods2,263 1,122 
Total inventories$5,159 $2,605 
(1) In fiscal years 2023 and 2022, we recorded an inventory reserve expense of approximately $1.04 billion and $173 million in cost of revenue, respectively.
 January 29,
2023
January 30,
2022
Estimated
Useful Life
(In millions)(In years)
Property and Equipment:
Land$218 $218 (A)
Buildings, leasehold improvements, and furniture1,598 874 (B)
Equipment, compute hardware, and software4,303 2,852 
3-5
Construction in process382 737 (C)
Total property and equipment, gross6,501 4,681  
Accumulated depreciation and amortization(2,694)(1,903) 
Total property and equipment, net$3,807 $2,778  
(A)Land is a non-depreciable asset.
(B)The estimated useful lives of our buildings are up to thirty years. Leasehold improvements and finance leases are amortized based on the lesser of either the asset’s estimated useful life or the expected lease term.
(C)Construction in process represents assets that are not available for their intended use as of the balance sheet date.
Depreciation expense for fiscal years 2023, 2022, and 2021 was $844 million, $611 million, and $486 million, respectively.
Accumulated amortization of leasehold improvements and finance leases was $327 million and $265 million as of January 29, 2023 and January 30, 2022, respectively.
Property, equipment and intangible assets acquired by assuming related liabilities during fiscal years 2023, 2022, and 2021 were $374 million, $258 million, and $157 million, respectively.
 January 29,
2023
January 30,
2022
Other assets:(In millions)
Prepaid supply agreements$2,989 $1,747 
Prepaid royalties387 409 
Investment in non-affiliated entities299 266 
Advanced consideration for acquisition (1)— 1,353 
Other145 66 
Total other assets$3,820 $3,841 
(1)Refer to Note 2 - Business Combination for further details on the Arm acquisition.
 January 29,
2023
January 30,
2022
(In millions)
Accrued and Other Current Liabilities:
Customer program accruals$1,196 $1,000 
Excess inventory purchase obligations (1)954 196 
Accrued payroll and related expenses530 409 
Taxes payable467 132 
Deferred revenue (2)354 300 
Operating leases176 144 
Other443 371 
Total accrued and other current liabilities$4,120 $2,552 
(1)In fiscal years 2023 and 2022, we recorded an expense of approximately $1.13 billion and $181 million, respectively, in cost of revenue for inventory purchase obligations in excess of our current demand projections, and cancellation and underutilization penalties.
(2)Deferred revenue primarily includes customer advances and deferrals related to license and development arrangements, support for hardware and software, and cloud services.
 January 29,
2023
January 30,
2022
(In millions)
Other Long-Term Liabilities:
Income tax payable (1)$1,204 $980 
Deferred income tax247 245 
Deferred revenue (2)218 202 
Licenses payable181 77 
Other63 49 
Total other long-term liabilities$1,913 $1,553 
(1)Income tax payable is comprised of the long-term portion of the one-time transition tax payable, unrecognized tax benefits, and related interest and penalties.
(2)Deferred revenue primarily includes deferrals related to support for hardware and software.
Deferred Revenue
The following table shows the changes in deferred revenue during fiscal years 2023 and 2022.
 January 29,
2023
January 30,
2022
(In millions)
Balance at beginning of period$502 $451 
Deferred revenue added during the period830 821 
Addition due to business combinations— 
Revenue recognized during the period(760)(778)
Balance at end of period$572 $502 
Revenue related to remaining performance obligations represents the contracted license and development arrangements and support for hardware and software. This includes deferred revenue currently recorded and amounts that will be invoiced in future periods. As of January 29, 2023, $652 million of revenue related to
performance obligations had not been recognized, of which we expect to recognize approximately 47% over the next twelve months and the remainder thereafter. This excludes revenue related to performance obligations for contracts with a length of one year or less.
v3.22.4
Derivative Financial Instruments
12 Months Ended
Jan. 29, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments Derivative Financial Instruments
We enter into foreign currency forward contracts to mitigate the impact of foreign currency exchange rate movements on our operating expenses. These contracts are designated as cash flow hedges for hedge accounting treatment. Gains or losses on the contracts are recorded in accumulated other comprehensive income or loss and reclassified to operating expense when the related operating expenses are recognized in earnings or ineffectiveness should occur. The fair value of the contracts was not significant as of January 29, 2023 and January 30, 2022.
We enter into foreign currency forward contracts to mitigate the impact of foreign currency movements on monetary assets and liabilities that are denominated in currencies other than U.S. dollar. These forward contracts were not designated for hedge accounting treatment. Therefore, the change in fair value of these contracts is recorded in other income or expense and offsets the change in fair value of the hedged foreign currency denominated monetary assets and liabilities, which is also recorded in other income or expense.
The table below presents the notional value of our foreign currency forward contracts outstanding as of January 29, 2023 and January 30, 2022:
January 29,
2023
January 30,
2022
 (In millions)
Designated as cash flow hedges$1,128 $1,023 
Non-designated hedges$366 $408 
As of January 29, 2023, all designated foreign currency forward contracts mature within eighteen months. The expected realized gains and losses deferred into accumulated other comprehensive income (loss) related to foreign currency forward contracts within the next twelve months was not significant.
During fiscal years 2023 and 2022, the impact of derivative financial instruments designated for hedge accounting treatment on other comprehensive income or loss was not significant and all such instruments were determined to be highly effective.
v3.22.4
Debt
12 Months Ended
Jan. 29, 2023
Debt Disclosure [Abstract]  
Debt Debt
Long-Term Debt
In June 2021, March 2020, and September 2016, we issued a total of $5.00 billion, $5.00 billion, and $2.00 billion aggregate principal of senior notes, respectively. The net proceeds from these offerings were $4.98 billion, $4.97 billion, and $1.98 billion, respectively, after deducting debt discount and issuance costs.
In fiscal year 2022, we repaid the $1.00 billion of 2.20% Notes Due 2021.
The carrying value of the Notes, the calendar year of maturity, and the associated interest rates were as follows:
 Expected
Remaining Term (years)
Effective
Interest Rate
January 29,
2023
January 30,
2022
   (In millions)
0.309% Notes Due 2023
0.40.41%$1,250 $1,250 
0.584% Notes Due 2024
1.40.66%1,250 1,250 
3.20% Notes Due 2026
3.63.31%1,000 1,000 
1.55% Notes Due 2028
5.41.64%1,250 1,250 
2.85% Notes Due 2030
7.22.93%1,500 1,500 
2.00% Notes Due 2031
8.42.09%1,250 1,250 
3.50% Notes Due 2040
17.23.54%1,000 1,000 
3.50% Notes Due 2050
27.23.54%2,000 2,000 
3.70% Notes Due 2060
37.23.73%500 500 
Unamortized debt discount and issuance costs  (47)(54)
Net carrying amount  10,953 10,946 
Less short-term portion(1,250)— 
Total long-term portion$9,703 $10,946 
All our notes are unsecured senior obligations. All existing and future liabilities of our subsidiaries will be effectively senior to the notes. Our notes pay interest semi-annually. We may redeem each of our notes prior to maturity, subject to a make-whole premium as defined in the applicable form of note.
As of January 29, 2023, we were in compliance with the required covenants, which are non-financial in nature, under the Notes.
Commercial Paper
We have a $575 million commercial paper program to support general corporate purposes. As of January 29, 2023, we had not issued any commercial paper.
v3.22.4
Commitments and Contingencies
12 Months Ended
Jan. 29, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Purchase Obligations
Our purchase obligations reflect our commitments to purchase components used to manufacture our products, including long-term supply agreements, certain software and technology licenses, other goods and services and long-lived assets.
We have entered into several long-term supply agreements, under which we have made advance payments and have $810 million remaining unpaid. As of January 29, 2023, we had outstanding inventory purchase and long-term supply obligations totaling $4.92 billion, inclusive of the $810 million. Under our manufacturing relationships with our foundry suppliers, subcontractors and contract manufacturers, cancellation of outstanding purchase commitments is generally allowed but may result in the payment of costs incurred through the date of cancellation. Other non-inventory purchase obligations of $3.14 billion include $2.23 billion of multi-year cloud service agreements.
Total future purchase commitments as of January 29, 2023, are as follows:
Commitments
 (In millions)
Fiscal Year: 
2024$5,230 
2025983 
2026679 
2027622 
2028296 
2029 and thereafter253 
Total$8,063 
Accrual for Product Warranty Liabilities
The estimated amount of product warranty liabilities was $82 million and $46 million as of January 29, 2023 and January 30, 2022, respectively. The estimated product returns and estimated product warranty activity consisted of the following:
Year Ended
January 29,January 30,January 31,
202320222021
(In millions)
Balance at beginning of period
$46 $22 $15 
Additions
145 4028
Utilization
(109)(16)(21)
Balance at end of period
$82 $46 $22 
In the second quarter of fiscal year 2023, we recorded $122 million in product warranty liabilities primarily related to a defect identified in a third-party component embedded in certain Data Center products. In the third quarter of fiscal year 2023, we recognized a warranty-related benefit of approximately $70 million in cost of revenue due to favorable product recovery.
In connection with certain agreements that we have entered in the past, we have provided indemnities for matters such as tax, product, and employee liabilities. We have included intellectual property indemnification provisions in our technology-related agreements with third parties. Maximum potential future payments cannot be estimated because many of these agreements do not have a maximum stated liability. We have not recorded any liability in our Consolidated Financial Statements for such indemnifications.
Litigation
Securities Class Action and Derivative Lawsuits
The plaintiffs in the putative securities class action lawsuit, captioned 4:18-cv-07669-HSG, initially filed on December 21, 2018 in the United States District Court for the Northern District of California, and titled In Re NVIDIA Corporation Securities Litigation, filed an amended complaint on May 13, 2020. The amended complaint asserted that NVIDIA and certain NVIDIA executives violated Section 10(b) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, and SEC Rule 10b-5, by making materially false or misleading statements related to channel inventory and the impact of cryptocurrency mining on GPU demand between May 10, 2017 and November 14, 2018. Plaintiffs also alleged that the NVIDIA executives who they named as defendants violated Section 20(a) of the Exchange Act. Plaintiffs sought class certification, an award of unspecified compensatory damages, an award of reasonable costs and expenses,
including attorneys’ fees and expert fees, and further relief as the Court may deem just and proper. On March 2, 2021, the district court granted NVIDIA’s motion to dismiss the complaint without leave to amend, entered judgment in favor of NVIDIA and closed the case. On March 30, 2021, plaintiffs filed an appeal from judgment in the United States Court of Appeals for the Ninth Circuit, case number 21-15604. Oral argument on the appeal was held on May 10, 2022.
The putative derivative lawsuit pending in the United States District Court for the Northern District of California, captioned 4:19-cv-00341-HSG, initially filed January 18, 2019 and titled In re NVIDIA Corporation Consolidated Derivative Litigation, was stayed pending resolution of the plaintiffs’ appeal in the In Re NVIDIA Corporation Securities Litigation action. On February 22, 2022, the court administratively closed the case, but stated that it would reopen the case once the appeal in the In Re NVIDIA Corporation Securities Litigation action is resolved. The lawsuit asserts claims, purportedly on behalf of us, against certain officers and directors of the Company for breach of fiduciary duty, unjust enrichment, waste of corporate assets, and violations of Sections 14(a), 10(b), and 20(a) of the Exchange Act based on the dissemination of allegedly false and misleading statements related to channel inventory and the impact of cryptocurrency mining on GPU demand. The plaintiffs are seeking unspecified damages and other relief, including reforms and improvements to NVIDIA’s corporate governance and internal procedures.
The putative derivative actions initially filed September 24, 2019 and pending in the United States District Court for the District of Delaware, Lipchitz v. Huang, et al. (Case No. 1:19-cv-01795-UNA) and Nelson v. Huang, et. al. (Case No. 1:19-cv-01798- UNA), remain stayed pending resolution of the plaintiffs’ appeal in the In Re NVIDIA Corporation Securities Litigation action. The lawsuits assert claims, purportedly on behalf of us, against certain officers and directors of the Company for breach of fiduciary duty, unjust enrichment, insider trading, misappropriation of information, corporate waste and violations of Sections 14(a), 10(b), and 20(a) of the Exchange Act based on the dissemination of allegedly false, and misleading statements related to channel inventory and the impact of cryptocurrency mining on GPU demand. The plaintiffs seek unspecified damages and other relief, including disgorgement of profits from the sale of NVIDIA stock and unspecified corporate governance measures.
Accounting for Loss Contingencies
As of January 29, 2023, we have not recorded any accrual for contingent liabilities associated with the legal proceedings described above based on our belief that liabilities, while possible, are not probable. Further, except as specifically described above, any possible loss or range of loss in these matters cannot be reasonably estimated at this time. We are engaged in legal actions not described above arising in the ordinary course of business and, while there can be no assurance of favorable outcomes, we believe that the ultimate outcome of these actions will not have a material adverse effect on our operating results, liquidity or financial position.
v3.22.4
Income Taxes
12 Months Ended
Jan. 29, 2023
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The income tax expense (benefit) applicable to income before income taxes consists of the following:
 Year Ended
 January 29,
2023
January 30,
2022
January 31,
2021
 (In millions)
Current income taxes:   
Federal$1,703 $482 $197 
State46 42 
Foreign228 71 161 
Total current1,977 595 359 
Deferred taxes:   
Federal(2,165)(420)(246)
Foreign14 (36)
Total deferred(2,164)(406)(282)
Income tax expense (benefit)$(187)$189 $77 
Income before income tax consists of the following:
 Year Ended
 January 29,
2023
January 30,
2022
January 31,
2021
 (In millions)
U.S.$3,477 $8,446 $1,437 
Foreign704 1,495 2,972 
Income before income tax$4,181 $9,941 $4,409 
The income tax expense (benefit) differs from the amount computed by applying the U.S. federal statutory rate of 21% to income before income taxes as follows:
 Year Ended
 January 29,
2023
January 30,
2022
January 31,
2021
 (In millions, except percentages)
Tax expense computed at federal statutory rate$878 21.0 %$2,088 21.0 %$926 21.0 %
Expense (benefit) resulting from:
Acquisition termination cost261 6.2 %— — %— — %
State income taxes, net of federal tax effect50 1.2 %42 0.4 %10 0.2 %
Foreign-derived intangible income(739)(17.7)%(520)(5.2)%— — %
Stock-based compensation(309)(7.4)%(337)(3.4)%(136)(3.1)%
U.S. federal research and development tax credit(278)(6.6)%(289)(2.9)%(173)(3.9)%
Foreign tax rate differential(83)(2.0)%(497)(5.0)%(561)(12.7)%
IP domestication— — %(244)(2.5)%— — %
Other33 0.8 %(54)(0.5)%11 0.2 %
Income tax expense (benefit)$(187)(4.5)%$189 1.9 %$77 1.7 %
The tax effect of temporary differences that gives rise to significant portions of the deferred tax assets and liabilities are presented below: 
 January 29,
2023
January 30,
2022
 (In millions)
Deferred tax assets: 
Capitalized research and development expenditure (1)$1,859 $508 
Research and other tax credit carryforwards951 798 
GILTI deferred tax assets800 378 
Accruals and reserves, not currently deductible for tax purposes686 258 
Net operating loss and capital loss carryforwards409 118 
Operating lease liabilities193 125 
Stock-based compensation99 86 
Property, equipment and intangible assets66 22 
Other deferred tax assets91 22 
Gross deferred tax assets5,154 2,315 
Less valuation allowance(1,484)(907)
Total deferred tax assets3,670 1,408 
Deferred tax liabilities:  
Unremitted earnings of foreign subsidiaries(228)(150)
Operating lease assets(179)(113)
Acquired intangibles(115)(169)
Gross deferred tax liabilities(522)(432)
Net deferred tax asset (2)$3,148 $976 
(1) Capitalized research and development deferred tax assets were previously included in Property, equipment and intangible assets.
(2) Net deferred tax asset includes long-term deferred tax assets of $3.40 billion and $1.22 billion and long-term deferred tax liabilities of $247 million and $245 million for fiscal years 2023 and 2022, respectively. Long-term deferred tax liabilities are included in other long-term liabilities on our Consolidated Balance Sheets.
As of January 29, 2023, we intend to indefinitely reinvest approximately $1.05 billion and $245 million of cumulative undistributed earnings held by certain subsidiaries in Israel and the United Kingdom, respectively. We have not provided the amount of unrecognized deferred tax liabilities for temporary differences related to these investments as the determination of such amount is not practicable.
As of January 29, 2023 and January 30, 2022, we had a valuation allowance of $1.48 billion and $907 million, respectively, related to capital loss carryforwards, state, and certain other deferred tax assets that management determined not likely to be realized due, in part, to jurisdictional projections of future taxable income, including capital gains. To the extent realization of the deferred tax assets becomes more-likely-than-not, we would recognize such deferred tax assets as income tax benefits during the period.
As of January 29, 2023, we had U.S. federal, state and foreign net operating loss carryforwards of $363 million, $329 million and $329 million, respectively. The federal and state carryforwards will begin to expire in fiscal years 2026 and 2024, respectively. The foreign net operating loss carryforwards of $329 million may be carried forward indefinitely. As of January 29, 2023, we had federal research tax credit carryforwards of $26 million, before the impact of uncertain tax positions, that will begin to expire in fiscal year 2024. We have state research tax credit carryforwards of $1.49 billion, before the impact of uncertain tax positions. $1.41 billion is attributable to the State of California and may be carried over indefinitely and $83 million is attributable to various other states and will begin to expire in fiscal year 2024. As of January 29, 2023, we had federal capital loss carryforwards of $1.38 billion that will begin to expire in fiscal year 2024.
Our tax attributes remain subject to audit and may be adjusted for changes or modification in tax laws, other authoritative interpretations thereof, or other facts and circumstances. Utilization of tax attributes may also
be subject to limitations due to ownership changes and other limitations provided by the Internal Revenue Code and similar state and foreign tax provisions. If any such limitations apply, the tax attributes may expire or be denied before utilization.
A reconciliation of gross unrecognized tax benefits is as follows:
 January 29,
2023
January 30,
2022
January 31,
2021
 (In millions)
Balance at beginning of period$1,013 $776 $583 
Increases in tax positions for current year268 246 158 
Increases in tax positions for prior years14 60 
Decreases in tax positions for prior years(15)(4)(11)
Settlements(9)(8)(5)
Lapse in statute of limitations(20)(11)(9)
Balance at end of period$1,238 $1,013 $776 
Included in the balance of unrecognized tax benefits as of January 29, 2023 are $770 million of tax benefits that would affect our effective tax rate if recognized.
We classify an unrecognized tax benefit as a current liability, or amount refundable, to the extent that we anticipate payment or receipt of cash for income taxes within one year. The amount is classified as a long-term liability, or reduction of long-term amount refundable, if we anticipate payment or receipt of cash for income taxes during a period beyond a year.
We include interest and penalties related to unrecognized tax benefits as a component of income tax expense. We recognized net interest and penalties related to unrecognized tax benefits in income tax expense line of our consolidated statements of income of $33 million, $14 million, and $7 million during fiscal years 2023, 2022 and 2021, respectively. As of January 29, 2023 and January 30, 2022, we have accrued $95 million and $59 million, respectively, for the payment of interest and penalties related to unrecognized tax benefits, which is not included as a component of our gross unrecognized tax benefits.
While we believe that we have adequately provided for all tax positions, amounts asserted by tax authorities could be greater or less than our accrued position. Accordingly, our provisions on federal, state and foreign tax-related matters to be recorded in the future may change as revised estimates are made or the underlying matters are settled or otherwise resolved. As of January 29, 2023, we have not identified any positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly increase or decrease within the next twelve months.
We are subject to taxation by taxing authorities both in the United States and other countries. As of January 29, 2023, the significant tax jurisdictions that may be subject to examination include China, Germany, Hong Kong, India, Israel, Taiwan, United Kingdom, and the United States for fiscal years 2005 through 2022. As of January 29, 2023, the significant tax jurisdictions for which we are currently under examination include Germany, India, Israel, and the United States for fiscal years 2005 through 2022.
v3.22.4
Shareholders’ Equity
12 Months Ended
Jan. 29, 2023
Equity [Abstract]  
Shareholders’ Equity Shareholders’ Equity
Capital Return Program
During fiscal year 2023, we repurchased 63 million shares for $10.04 billion. Since the inception of our share repurchase program through January 29, 2023, we have repurchased an aggregate of 1.10 billion shares under our share repurchase program for a total cost of $17.12 billion. As of January 29, 2023, we were authorized, subject to certain specifications, to repurchase an additional $7.23 billion of shares through December 2023.
During fiscal years 2023, 2022, and 2021, we paid $398 million, $399 million, and $395 million in cash dividends to our shareholders, respectively. Our cash dividend program and the payment of future cash dividends under that program are subject to our Board of Directors' continuing determination that the dividend program and the declaration of dividends thereunder are in the best interests of our shareholders.
In fiscal year 2022, we retired our existing 349 million treasury shares. These shares assumed the status of authorized and unissued shares upon retirement. The excess of repurchase price over par value was allocated between additional paid-in capital and retained earnings, resulting in a reduction in additional paid-in capital by $20 million and retained earnings by $12.0 billion. Any future repurchased shares will assume the status of authorized and unissued shares.
v3.22.4
Employee Retirement Plans
12 Months Ended
Jan. 29, 2023
Retirement Benefits [Abstract]  
Employee Retirement Plans Employee Retirement PlansWe provide tax-qualified defined contribution plans to eligible employees in the U.S. and certain other countries. Our contribution expense for fiscal years 2023, 2022, and 2021 was $227 million, $168 million, and $120 million, respectively.
v3.22.4
Segment Information
12 Months Ended
Jan. 29, 2023
Segment Reporting [Abstract]  
Segment Information Segment Information 
Our Chief Executive Officer, who is considered to be our chief operating decision maker, or CODM, reviews financial information presented on an operating segment basis for purposes of making decisions and assessing financial performance.
The Compute & Networking segment includes our Data Center accelerated computing platform; networking; automotive AI Cockpit, autonomous driving development agreements, and autonomous vehicle solutions; electric vehicle computing platforms; Jetson for robotics and other embedded platforms; and NVIDIA AI Enterprise and other software; and CMP.
The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; vGPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse Enterprise software for building and operating metaverse and 3D internet applications.
Operating results by segment include costs or expenses that are directly attributable to each segment, and costs or expenses that are leveraged across our unified architecture and therefore allocated between our two segments.
The “All Other” category includes the expenses that our CODM does not assign to either Compute & Networking or Graphics for purposes of making operating decisions or assessing financial performance. The expenses include stock-based compensation expense, acquisition-related and other costs, corporate infrastructure and support costs, restructuring costs, acquisition termination cost, IP-related and legal settlement costs, contributions, and other non-recurring charges and benefits that our CODM deems to be enterprise in nature.
Our CODM does not review any information regarding total assets on a reportable segment basis. Depreciation and amortization expense directly attributable to each reportable segment is included in operating results for each segment. However, the CODM does not evaluate depreciation and amortization expense by operating segment and, therefore, it is not separately presented. There is no intersegment revenue. The accounting policies for segment reporting are the same as for our consolidated financial statements. The table below presents details of our reportable segments and the “All Other” category.
 Compute & NetworkingGraphicsAll OtherConsolidated
(In millions)
Year Ended January 29, 2023:
   
Revenue$15,068 $11,906 $— $26,974 
Operating income (loss)$5,083 $4,552 $(5,411)$4,224 
Year Ended January 30, 2022:
   
Revenue$11,046 $15,868 $— $26,914 
Operating income (loss)$4,598 $8,492 $(3,049)$10,041 
Year Ended January 31, 2021:
   
Revenue$6,841 $9,834 $— $16,675 
Operating income (loss)$2,548 $4,612 $(2,628)$4,532 
Year Ended
January 29,
2023
January 30,
2022
January 31,
2021
(In millions)
Reconciling items included in "All Other" category:
Stock-based compensation expense$(2,710)$(2,004)$(1,397)
Acquisition termination cost(1,353)— — 
Acquisition-related and other costs(674)(636)(836)
Unallocated cost of revenue and operating expenses(595)(399)(357)
Restructuring costs and other(54)— — 
IP-related and legal settlement costs(23)(10)(38)
Contributions(2)— — 
Total$(5,411)$(3,049)$(2,628)
Revenue by geographic region is allocated to individual countries based on the billing location of the customer. End customer location may be different than our customer’s billing location. The following table summarizes information pertaining to our revenue from customers based on the invoicing address by geographic regions: 
 Year Ended
 January 29,
2023
January 30,
2022
January 31,
2021
Revenue:(In millions)
United States$8,292 $4,349 $3,214 
Taiwan6,986 8,544 4,531 
China (including Hong Kong)5,785 7,111 3,886 
Other countries5,911 6,910 5,044 
Total revenue$26,974 $26,914 $16,675 
No customer represented 10% or more of total revenue for fiscal years 2023, 2022 and 2021.
Two customers accounted for 14% and 11% of our accounts receivable balance as of January 29, 2023. Two customers each accounted for 11% of our accounts receivable balance as of January 30, 2022.
The following table summarizes information pertaining to our revenue by each of the specialized markets we serve:
 Year Ended
 January 29,
2023
January 30,
2022
January 31,
2021
Revenue:(In millions)
Data Center$15,005 $10,613 $6,696 
Gaming9,067 12,462 7,759 
Professional Visualization1,544 2,111 1,053 
Automotive903 566 536 
OEM & Other455 1,162 631 
Total revenue$26,974 $26,914 $16,675 
The following table presents summarized information for long-lived assets by country. Long-lived assets consist of property and equipment and exclude other assets, operating lease assets, goodwill, and intangible assets.
 January 29,
2023
January 30,
2022
Long-lived assets:(In millions)
United States$2,587 $2,023 
Taiwan702 379 
Israel283 185 
Other countries235 191 
Total long-lived assets$3,807 $2,778 
v3.22.4
Schedule II - Valuation and Qualifying Accounts
12 Months Ended
Jan. 29, 2023
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
Schedule II - Valuation and Qualifying Accounts
SCHEDULE II – VALUATION AND QUALIFYING ACCOUNTS
DescriptionBalance at
Beginning of Period
Additions Deductions Balance at
End of Period
 (In millions)
Fiscal year 2023
      
Allowance for doubtful accounts$$— (1)$— (1)$
Sales return allowance$13 $104 (2)$(91)(4)$26 
Deferred tax valuation allowance$907 $577 (3)$— $1,484 
Fiscal year 2022
      
Allowance for doubtful accounts$$— (1)$— (1)$
Sales return allowance$17 $19 (2)$(23)(4)$13 
Deferred tax valuation allowance$728 $179 (3)$— $907 
Fiscal year 2021
      
Allowance for doubtful accounts$$(1)$— (1)$
Sales return allowance$$30 (2)$(22)(4)$17 
Deferred tax valuation allowance$621 $107 (3)$— $728 
(1)Additions represent either expense or acquired balances and deductions represent write-offs.
(2)Additions represent estimated product returns charged as a reduction to revenue or an acquired balance.
(3)Additional valuation allowance on deferred tax assets not likely to be realized. Fiscal year 2023 includes additional valuation allowance on capital loss carryforwards, state, and certain other deferred tax assets. Refer to Note 14 of the Notes to the Consolidated Financial Statements in Part IV, Item 15 of this Annual Report on Form 10-K for additional information.
(4)Represents sales returns.
v3.22.4
Organization and Summary of Significant Accounting Policies (Policies)
12 Months Ended
Jan. 29, 2023
Accounting Policies [Abstract]  
Our Company
Our Company
Headquartered in Santa Clara, California, NVIDIA was incorporated in California in April 1993 and reincorporated in Delaware in April 1998.
All references to “NVIDIA,” “we,” “us,” “our” or the “Company” mean NVIDIA Corporation and its subsidiaries.
Fiscal Year
Fiscal Year
We operate on a 52- or 53-week year, ending on the last Sunday in January. Fiscal years 2023 and 2022 were both 52-week years. Fiscal year 2021 was a 53-week year.
Reclassifications
Reclassifications
Certain prior fiscal year balances have been reclassified to conform to the current fiscal year presentation.
Prior period intangible asset gross carrying amount and accumulated amortization in Note 7 have been adjusted to write off immaterial fully amortized intangible assets as of January 30, 2022.
Principles of Consolidation
Principles of Consolidation
Our consolidated financial statements include the accounts of NVIDIA Corporation and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from our estimates. On an on-going basis, we evaluate our estimates, including those related to revenue recognition, cash equivalents and marketable securities, accounts receivable, inventories, income taxes, goodwill, stock-based compensation, litigation, investigation and settlement costs, restructuring and other charges, and other contingencies. The inputs into our judgments and estimates consider the economic implications of COVID-19. These estimates are based on historical facts and various other assumptions that we believe are reasonable.
In February 2023, we completed an assessment of the useful lives of our property, plant, and equipment. Based on advances in technology and usage rate, we increased the estimated useful life of a majority of the server, storage, and network equipment from three to a range of four to five years, and assembly and test equipment from five to seven years. This change in accounting estimate became effective at the beginning of fiscal year 2024. Based on the carrying amounts of a majority of our server, storage, network, and assembly and test equipment, net in use as of the end of fiscal year 2023, it is estimated this change will increase our fiscal year 2024 operating income by $133 million as a result of the reduction in depreciation expense.
Revenue Recognition
Revenue Recognition
We derive our revenue from product sales, including hardware and systems, license and development arrangements, software licensing, and cloud services. We determine revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract (where revenue is allocated on a relative standalone selling price basis by maximizing the use of observable inputs to determine the standalone selling price for each performance obligation); and (5) recognition of revenue when, or as, we satisfy a performance obligation.
Product Sales Revenue
Revenue from product sales is recognized upon transfer of control of products to customers in an amount that reflects the consideration we expect to receive in exchange for those products. Certain products are
sold with support or an extended warranty for the incorporated system, hardware, and/or software. Support and extended warranty revenue are recognized ratably over the service period, or as services are performed. Revenue is recognized net of allowances for returns, customer programs and any taxes collected from customers.
For products sold with a right of return, we record a reduction to revenue by establishing a sales return allowance for estimated product returns at the time revenue is recognized, based primarily on historical return rates. However, if product returns for a fiscal period are anticipated to exceed historical return rates, we may determine that additional sales return allowances are required to properly reflect our estimated exposure for product returns.
Our customer programs involve rebates, which are designed to serve as sales incentives to resellers of our products in various target markets, and marketing development funds, or MDFs, which represent monies paid to our partners that are earmarked for market segment development and are designed to support our partners’ activities while also promoting NVIDIA products. We account for customer programs as a reduction to revenue and accrue for potential rebates and MDFs based on the amount we expect to be claimed by customers.
License and Development Arrangements
Our license and development arrangements with customers typically require significant customization of our IP components. As a result, we recognize the revenue from the license and the revenue from the development services as a single performance obligation over the period in which the development services are performed. We measure progress to completion based on actual cost incurred to date as a percentage of the estimated total cost required to complete each project. If a loss on an arrangement becomes probable during a period, we record a provision for such loss in that period.
Software Licensing
Our software licenses provide our customers with a right to use the software when it is made available to the customer. Customers may purchase either perpetual licenses or subscriptions to licenses, which differ mainly in the duration over which the customer benefits from the software. Software licenses are frequently sold along with the right to receive, on a when-and-if available basis, future unspecified software updates and upgrades. Revenue from software licenses is recognized up front when the software is made available to the customer. Software support revenue is recognized ratably over the service period, or as services are performed.
Cloud Services
Cloud services, which allow customers to use hosted software and hardware infrastructure without taking possession of the software or hardware, are provided on a subscription basis or a combination of subscription plus usage. Revenue related to subscription-based cloud services is recognized ratably over the contract period. Revenue related to cloud services based on usage is recognized as usage occurs.
Product Warranties
Product Warranties
We generally offer a limited warranty to end-users that ranges from one to three years for products in order to repair or replace products for any manufacturing defects or hardware component failures. Cost of revenue includes the estimated cost of product warranties that are calculated at the point of revenue recognition. Under limited circumstances, we may offer an extended limited warranty to customers for certain products. We also accrue for known warranty and indemnification issues if a loss is probable and can be reasonably estimated.
Stock-based Compensation
Stock-based Compensation
We use the closing trading price of our common stock on the date of grant, minus a dividend yield discount, as the fair value of awards of restricted stock units, or RSUs, and performance stock units that are based on our corporate financial performance targets, or PSUs. We use a Monte Carlo simulation on the date of grant to estimate the fair value of performance stock units that are based on market conditions, or market-based PSUs. The compensation expense for RSUs and market-based PSUs is recognized using a straight-line
attribution method over the requisite employee service period while compensation expense for PSUs is recognized using an accelerated amortization model. We estimate the fair value of shares to be issued under our employee stock purchase plan, or ESPP, using the Black-Scholes model at the commencement of an offering period in March and September of each year. Stock-based compensation for our ESPP is expensed using an accelerated amortization model. Additionally, we estimate forfeitures at least annually based on historical experience and revise the estimates of forfeiture in subsequent periods if actual forfeitures differ from those estimates.
Litigation, Investigation and Settlement Costs
Litigation, Investigation and Settlement Costs
We currently, are, and will likely continue to be subject to claims, litigation, and other actions, including potential regulatory proceedings, involving patent and other intellectual property matters, taxes, labor and employment, competition and antitrust, commercial disputes, goods and services offered by us and by third parties, and other matters. There are many uncertainties associated with any litigation or investigation, and we cannot be certain that these actions or other third-party claims against us will be resolved without litigation, fines and/or substantial settlement payments or judgments. If information becomes available that causes us to determine that a loss in any of our pending litigation, investigations or settlements is probable, and we can reasonably estimate the loss associated with such events, we will record the loss in accordance with U.S. GAAP. However, the actual liability in any such litigation or investigation may be materially different from our estimates, which could require us to record additional costs.
Foreign Currency Remeasurement
Foreign Currency Remeasurement
We use the United States dollar as our functional currency for our subsidiaries. Foreign currency monetary assets and liabilities are remeasured into United States dollars at end-of-period exchange rates. Non-monetary assets and liabilities such as property and equipment and equity are remeasured at historical exchange rates. Revenue and expenses are remeasured at exchange rates in effect during each period, except for those expenses related to non-monetary balance sheet amounts, which are remeasured at historical exchange rates. Gains or losses from foreign currency remeasurement are included in earnings in our Consolidated Statements of Income and to date have not been significant.
Income Taxes
Income Taxes
We recognize federal, state and foreign current tax liabilities or assets based on our estimate of taxes payable or refundable in the current fiscal year by tax jurisdiction. We recognize federal, state and foreign deferred tax assets or liabilities, as appropriate, for our estimate of future tax effects attributable to temporary differences and carryforwards; and we record a valuation allowance to reduce any deferred tax assets by the amount of any tax benefits that, based on available evidence and judgment, are not expected to be realized.
Our calculation of deferred tax assets and liabilities is based on certain estimates and judgments and involves dealing with uncertainties in the application of complex tax laws. Our estimates of deferred tax assets and liabilities may change based, in part, on added certainty or finality to an anticipated outcome, changes in accounting standards or tax laws in the United States, or foreign jurisdictions where we operate, or changes in other facts or circumstances. In addition, we recognize liabilities for potential United States and foreign income tax contingencies based on our estimate of whether, and the extent to which, additional taxes may be due. If we determine that payment of these amounts is unnecessary or if the recorded tax liability is less than our current assessment, we may be required to recognize an income tax benefit or additional income tax expense in our financial statements accordingly.
As of January 29, 2023, we had a valuation allowance of $1.48 billion related to capital loss carryforwards, state, and certain other deferred tax assets that management determined are not likely to be realized due to jurisdictional projections of future taxable income, including capital gains, tax attributes usage limitation by certain jurisdictions, and potential utilization limitations of tax attributes acquired as a result of stock ownership changes. To the extent realization of the deferred tax assets becomes more-likely-than-not, we would recognize such deferred tax assets as an income tax benefit during the period.
We recognize the benefit from a tax position only if it is more-likely-than-not that the position would be sustained upon audit based solely on the technical merits of the tax position. Our policy is to include interest and penalties related to unrecognized tax benefits as a component of income tax expense.
Net Income Per Share Net Income Per ShareBasic net income per share is computed using the weighted average number of common shares outstanding during the period. Diluted net income per share is computed using the weighted average number of common and potentially dilutive shares outstanding during the period, using the treasury stock method. Under the treasury stock method, the effect of equity awards outstanding is not included in the computation of diluted net income per share for periods when their effect is anti-dilutive.
Cash and Cash Equivalents and Marketable Securities
Cash and Cash Equivalents and Marketable Securities
We consider all highly liquid investments that are readily convertible into cash and have an original maturity of three months or less at the time of purchase to be cash equivalents. Marketable securities consist of highly liquid debt investments with maturities of greater than three months when purchased. We currently classify our investments as current based on the nature of the investments and their availability for use in current operations.
We classify our cash equivalents and marketable securities related to debt securities at the date of acquisition as available-for-sale. These available-for-sale debt securities are reported at fair value with the related unrealized gains and losses included in accumulated other comprehensive income or loss, a component of shareholders’ equity, net of tax. The fair value of interest-bearing debt securities includes accrued interest. Realized gains and losses on the sale of marketable securities are determined using the specific-identification method and recorded in the other income (expense), net, section of our Consolidated Statements of Income.
Available-for-sale debt investments are subject to a periodic impairment review. If the estimated fair value of available-for-sale debt securities is less than its amortized cost basis, we determine if the difference, if any, is caused by expected credit losses and write-down the amortized cost basis of the securities if it is more likely than not we will be required or we intend to sell the securities before recovery of its amortized cost basis. Allowances for credit losses and write-downs are recognized in the other income (expense), net section of our Consolidated Statements of Income.
Cash and Cash Equivalents and Marketable Securities
Cash and Cash Equivalents and Marketable Securities
We consider all highly liquid investments that are readily convertible into cash and have an original maturity of three months or less at the time of purchase to be cash equivalents. Marketable securities consist of highly liquid debt investments with maturities of greater than three months when purchased. We currently classify our investments as current based on the nature of the investments and their availability for use in current operations.
We classify our cash equivalents and marketable securities related to debt securities at the date of acquisition as available-for-sale. These available-for-sale debt securities are reported at fair value with the related unrealized gains and losses included in accumulated other comprehensive income or loss, a component of shareholders’ equity, net of tax. The fair value of interest-bearing debt securities includes accrued interest. Realized gains and losses on the sale of marketable securities are determined using the specific-identification method and recorded in the other income (expense), net, section of our Consolidated Statements of Income.
Available-for-sale debt investments are subject to a periodic impairment review. If the estimated fair value of available-for-sale debt securities is less than its amortized cost basis, we determine if the difference, if any, is caused by expected credit losses and write-down the amortized cost basis of the securities if it is more likely than not we will be required or we intend to sell the securities before recovery of its amortized cost basis. Allowances for credit losses and write-downs are recognized in the other income (expense), net section of our Consolidated Statements of Income.
Fair Value of Financial Instruments
Fair Value of Financial Instruments
The carrying value of cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate their fair values due to their relatively short maturities as of January 29, 2023 and January 30, 2022. Marketable securities are comprised of available-for-sale securities that are reported at fair value with the related unrealized gains or losses included in accumulated other comprehensive income or loss, a component of shareholders’ equity, net of tax. Fair value of the marketable securities is determined based on quoted market prices. Derivative instruments are recognized as either assets or liabilities and are measured at fair value. The accounting for changes in the fair value of a derivative depends on the intended use of the derivative and the resulting designation. For derivative instruments designated as fair value hedges, the gains or losses are recognized in earnings in the periods of change together with the offsetting losses or gains on the hedged items attributed to the risk being hedged. For derivative instruments designated as cash-flow hedges, the effective portion of the gains or losses on the derivatives is initially reported as a component of other comprehensive income or loss and is subsequently recognized in earnings when the hedged exposure is recognized in earnings. For derivative instruments not designated for hedge accounting, changes in fair value are recognized in earnings.
Concentration of Credit Risk
Concentration of Credit Risk
Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash equivalents, marketable securities, and accounts receivable. Our investment policy requires the purchase of highly-rated fixed income securities, the diversification of investment type and credit exposures, and includes certain limits on our portfolio duration. We perform ongoing credit evaluations of our customers’ financial condition and maintain an allowance for potential credit losses. This allowance consists of an amount
identified for specific customers and an amount based on overall estimated exposure. Our overall estimated exposure excludes amounts covered by credit insurance and letters of credit.
Inventories
Inventories
Inventory cost is computed on an adjusted standard basis, which approximates actual cost on an average or first-in, first-out basis. Inventory costs consist primarily of the cost of semiconductors, including wafer fabrication, assembly, testing and packaging, manufacturing support costs, including labor and overhead associated with such purchases, final test yield fallout, and shipping costs, as well as the cost of purchased memory products and other component parts. We charge cost of sales for inventory provisions to write-down our inventory to the lower of cost or net realizable value or for obsolete or excess inventory, and for excess product purchase commitments. Most of our inventory provisions relate to excess quantities of products, based on our inventory levels and future product purchase commitments compared to assumptions about future demand and market conditions. Once inventory has been written-off or written-down, it creates a new cost basis for the inventory that is not subsequently written-up. We record a liability for noncancelable purchase commitments with suppliers for quantities in excess of our future demand forecasts consistent with our valuation of obsolete or excess inventory.
Property and Equipment
Property and Equipment
Property and equipment are stated at cost. Depreciation of property and equipment is computed using the straight-line method based on the estimated useful lives of the assets, generally three to five years. Once an asset is identified for retirement or disposition, the related cost and accumulated depreciation or amortization are removed, and a gain or loss is recorded. The estimated useful lives of our buildings are up to thirty years. Depreciation expense includes the amortization of assets recorded under finance leases. Leasehold improvements and assets recorded under finance leases are amortized over the shorter of the expected lease term or the estimated useful life of the asset.
Leases
Leases
We determine if an arrangement is or contains a lease at inception. Operating leases with lease terms of more than 12 months are included in operating lease assets, accrued and other current liabilities, and long-term operating lease liabilities on our consolidated balance sheet. Operating lease assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments over the lease term.
Operating lease assets and liabilities are recognized based on the present value of the remaining lease payments discounted using our incremental borrowing rate. Operating lease assets also include initial direct costs incurred and prepaid lease payments, minus any lease incentives. Our lease terms include options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease expense is recognized on a straight-line basis over the lease term.
We combine the lease and non-lease components in determining the operating lease assets and liabilities.
Goodwill
Goodwill
Goodwill is subject to our annual impairment test during the fourth quarter of our fiscal year, or earlier if indicators of potential impairment exist. For the purposes of completing our impairment test, we perform either a qualitative or a quantitative analysis on a reporting unit basis. 
Qualitative factors include industry and market considerations, overall financial performance, and other relevant events and factors affecting the reporting units.
The quantitative impairment test considers both the income approach and the market approach to estimate a reporting unit’s fair value. The income and market valuation approaches consider factors that include, but are not limited to, prospective financial information, growth rates, residual values, discount rates and comparable multiples from publicly traded companies in our industry and require us to make certain assumptions and estimates regarding industry economic factors and the future profitability of our business.
Intangible Assets and Other Long-Lived Assets
Intangible Assets and Other Long-Lived Assets
Intangible assets primarily represent acquired intangible assets including developed technology, in-process research and development, or IPR&D, and customer relationships, as well as rights acquired under technology licenses, patents, and acquired IP. We currently amortize our intangible assets with finite lives over periods ranging from one to twenty years using a method that reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up or, if that pattern cannot be reliably determined, using a straight-line amortization method. We initially capitalize the fair value of IPR&D as an intangible asset with an indefinite life. When IPR&D projects are completed, we reclassify the IPR&D as an amortizable purchased intangible asset and amortize over the asset’s estimated useful life.
Long-lived assets, such as property and equipment and intangible assets subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. Recoverability of assets or asset groups to be held and used is measured by a comparison of the carrying amount of an asset or asset group to estimated undiscounted future cash flows expected to be generated by the asset or asset group. If the carrying amount of an asset or asset group exceeds its estimated future cash flows, an impairment charge is recognized for the amount by which the carrying amount of the asset or asset group exceeds the estimated fair value of the asset or asset group. Fair value is determined based on the estimated discounted future cash flows expected to be generated by the asset or asset group. Assets and liabilities to be disposed of would be separately presented in the Consolidated Balance Sheet and the assets would be reported at the lower of the carrying amount or fair value less costs to sell, and would no longer be depreciated.
Business Combination
Business Combination
We allocate the fair value of the purchase price of an acquisition to the tangible assets acquired, liabilities assumed, and intangible assets acquired, including IPR&D, based on their estimated fair values. The excess of the fair value of the purchase price over the fair values of these net tangible and intangible assets acquired is recorded as goodwill. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but our estimates and assumptions are inherently uncertain and subject to refinement. The estimates and assumptions used in valuing intangible assets include, but are not limited to, the amount and timing of projected future cash flows, discount rate used to determine the present value of these cash flows and asset lives. These estimates are inherently uncertain and, therefore, actual results may differ from the estimates made. As a result, during the measurement period of up to one year from the acquisition date, we may record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the fair value of the purchase price of an acquisition, whichever comes first, any subsequent adjustments are recorded to our Consolidated Statements of Income.
Acquisition-related expenses are recognized separately from the business combination and expensed as incurred.
Investment in Non-Affiliated Entities
Investment in Non-Affiliated Entities
Non-marketable equity investments in privately-held companies are recorded at fair value on a non-recurring basis only if an impairment or observable price adjustment occurs in the period with changes in fair value recorded through net income. These investments are valued using observable and unobservable inputs or data in an inactive market and the valuation requires our judgment due to the absence of market prices and inherent lack of liquidity. The estimated fair value is based on quantitative and qualitative factors including subsequent financing activities by the investee.
Marketable equity investments in publicly-held companies are recorded at fair value with the related unrealized and realized gains and losses recognized in other income (expense), net.
v3.22.4
Business Combination (Tables)
12 Months Ended
Jan. 29, 2023
Business Combination and Asset Acquisition [Abstract]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed
The aggregate purchase consideration has been allocated as follows (in millions):
Purchase Price
Cash paid for outstanding Mellanox ordinary shares (1)$7,033 
Cash for Mellanox equity awards (2)16 
Total cash consideration7,049 
Fair value of Mellanox equity awards assumed by NVIDIA (3)85 
Total purchase consideration$7,134 
Allocation
Cash and cash equivalents$115 
Marketable securities699 
Accounts receivable, net216 
Inventories320 
Prepaid expenses and other assets179 
Property and equipment, net144 
Goodwill3,431 
Intangible assets2,970 
Accounts payable(136)
Accrued and other current liabilities(236)
Income tax liability(191)
Deferred income tax liability(258)
Other long-term liabilities(119)
$7,134 

(1)    Represents the cash consideration of $125.00 per share paid to Mellanox shareholders for approximately 56 million shares of outstanding Mellanox ordinary shares.
(2)    Represents the cash consideration for the settlement of approximately 249 thousand Mellanox stock options held by employees and non-employee directors of Mellanox.
(3)    Represents the fair value of Mellanox’s stock-based compensation awards attributable to pre-combination services.
Schedule of Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination
The estimated fair value and useful life of the acquired intangible assets at the time of the acquisition are as follows:
Fair ValueUseful Lives
(In millions)
Developed technology (1)$1,640 5 years
Customer relationships (2)440 3 years
Order backlog (3)190 Based on actual shipments
Trade names (4)70 5 years
Total identified finite-lived intangible assets2,340 
IPR&D (5)630 N/A
Total identified intangible assets$2,970 

(1)    The fair value of developed technology was identified using the Multi-Period Excess Earnings Method.
(2)    Customer relationships represent the fair value of the existing relationships using the With and Without Method.
(3)    Order backlog represents primarily the fair value of purchase arrangements with customers using the Multi-Period Excess Earnings Method. The intangible asset was fully amortized as of January 31, 2021.
(4)    Trade names primarily relate to Mellanox trade names and fair value was determined by applying the Relief-from-Royalty Method under the income approach.
(5)    The fair value of IPR&D was determined using the Multi-Period Excess Earnings Method.
Schedule of Business Acquisition, Pro Forma Information
The following unaudited pro forma financial information summarizes the combined results of operations for NVIDIA and Mellanox as if the companies were combined as of the beginning of fiscal year 2020:
Pro Forma
 Year Ended
 January 31, 2021
(In millions)
Revenue$17,104 
Net income$4,757 
v3.22.4
Leases (Tables)
12 Months Ended
Jan. 29, 2023
Leases [Abstract]  
Schedule of Future Minimum Lease Payments
Future minimum lease payments under our non-cancelable operating leases as of January 29, 2023, are as follows:
Operating Lease Obligations
 (In millions)
Fiscal Year: 
2024$220 
2025198 
2026180 
2027166 
2028144 
2029 and thereafter323 
Total1,231 
Less imputed interest153 
Present value of net future minimum lease payments1,078 
Less short-term operating lease liabilities176 
Long-term operating lease liabilities$902 
Schedule of Other Information Related to Leases
Other information related to leases was as follows:
Year Ended
January 29, 2023January 30, 2022January 31, 2021
 (In millions)
Supplemental cash flows information 
Operating cash flows used for operating leases$184 $154 $141 
Operating lease assets obtained in exchange for lease obligations$358 $266 $200 
v3.22.4
Stock-Based Compensation (Tables)
12 Months Ended
Jan. 29, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense, Net of Amounts Capitalized as Inventory
Our Consolidated Statements of Income include stock-based compensation expense, net of amounts allocated to inventory, as follows:
 Year Ended
January 29,
2023
January 30,
2022
January 31,
2021
 (In millions)
Cost of revenue$138 $141 $88 
Research and development1,892 1,298 860 
Sales, general and administrative680 565 449 
Total$2,710 $2,004 $1,397 
Schedule of Equity Awards
The following is a summary of equity awards granted under our equity incentive plans:
Year Ended
January 29,
2023
January 30,
2022
January 31,
2021
(In millions, except per share data)
RSUs, PSUs and Market-based PSUs
Awards granted25 18 36 
Estimated total grant-date fair value$4,505 $3,492 $2,764 
Weighted average grant-date fair value per share$183.72 $190.69 $76.81 
ESPP
Shares purchased
Weighted average price per share$122.54 $56.36 $34.80 
Weighted average grant-date fair value per share$51.87 $23.24 $16.91 
Schedule of ESPP Valuation Assumptions
The fair value of shares issued under our ESPP have been estimated with the following assumptions:
 Year Ended
 January 29,
2023
January 30,
2022
January 31,
2021
(Using the Black-Scholes model)
ESPP
Weighted average expected life (in years)
0.1-2.0
0.1-2.0
0.1-2.0
Risk-free interest rate
—%-4.6%
—%-0.5%
0.1%-1.6%
Volatility
43%-72%
20%-58%
26%-89%
Dividend yield
0.1%
0.1%
0.1%-0.3%
Schedule of Equity Award Transactions
The following is a summary of our equity award transactions under our equity incentive plans: 
RSUs, PSUs and Market-based PSUs Outstanding
 Number of SharesWeighted Average Grant-Date Fair Value
(In millions, except per share data)
Balances, January 30, 202246 $114.19 
Granted25 $183.72 
Vested restricted stock(24)$100.06 
Canceled and forfeited(2)$141.17 
Balances, January 29, 202345 $158.45 
Vested and expected to vest after January 29, 202345 $158.35 
v3.22.4
Net Income Per Share (Tables)
12 Months Ended
Jan. 29, 2023
Earnings Per Share [Abstract]  
Schedule of Reconciliation of Numerators and Denominators of Basic and Diluted net Income Per Share Computations
The following is a reconciliation of the denominator of the basic and diluted net income per share computations for the periods presented:
 Year Ended
 January 29,
2023
January 30,
2022
January 31,
2021
 (In millions, except per share data)
Numerator:   
Net income$4,368 $9,752 $4,332 
Denominator:   
Basic weighted average shares2,487 2,496 2,467 
Dilutive impact of outstanding equity awards20 39 43 
Diluted weighted average shares2,507 2,535 2,510 
Net income per share:   
Basic (1)$1.76 $3.91 $1.76 
Diluted (2)$1.74 $3.85 $1.73 
Equity awards excluded from diluted net income per share because their effect would have been anti-dilutive
40 21 12 
(1)    Calculated as net income divided by basic weighted average shares.
(2)    Calculated as net income divided by diluted weighted average shares.
v3.22.4
Amortizable Intangible Assets (Tables)
12 Months Ended
Jan. 29, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of the Components of Our Amortizable Intangible Assets
The components of our amortizable intangible assets are as follows:
 January 29, 2023January 30, 2022
 
Gross
Carrying
Amount
Accumulated
Amortization
Net 
Carrying
Amount
Gross
Carrying
Amount
Accumulated
Amortization
Net 
Carrying
Amount
 (In millions)
Acquisition-related intangible assets (1)$3,093 $(1,614)$1,479 $3,061 $(947)$2,114 
Patents and licensed technology446 (249)197 446 (221)225 
Total intangible assets$3,539 $(1,863)$1,676 $3,507 $(1,168)$2,339 
(1)    During the first quarter of fiscal year 2023, we commenced amortization of a $630 million in-process research and development intangible asset related to our acquisition of Mellanox.
v3.22.4
Cash Equivalents and Marketable Securities (Tables)
12 Months Ended
Jan. 29, 2023
Investments, Debt and Equity Securities [Abstract]  
Schedule of Cash Equivalents and Marketable Securities
The following is a summary of cash equivalents and marketable securities as of January 29, 2023 and January 30, 2022:
 January 29, 2023
Amortized
Cost
Unrealized
Gain
Unrealized
Loss
Estimated
Fair Value
Reported as
 Cash EquivalentsMarketable Securities
 (In millions)
Corporate debt securities$4,809 $— $(12)$4,797 $1,087 $3,710 
Debt securities issued by the United States Treasury4,185 (44)4,142 — 4,142 
Debt securities issued by United States government agencies1,836 — (2)1,834 50 1,784 
Money market funds1,777 — — 1,777 1,777 — 
Certificates of deposit365 — — 365 134 231 
Foreign government bonds140 — — 140 100 40 
Total$13,112 $$(58)$13,055 $3,148 $9,907 
 January 30, 2022
Amortized
Cost
Unrealized
Gain
Unrealized
Loss
Estimated
Fair Value
Reported as
 Cash EquivalentsMarketable Securities
 (In millions)
Corporate debt securities$9,977 $— $(3)$9,974 $1,102 $8,872 
Debt securities issued by the United States Treasury7,314 — (14)7,300 — 7,300 
Debt securities issued by United States government agencies1,612 — — 1,612 256 1,356 
Certificates of deposit1,561 — — 1,561 21 1,540 
Money market funds316 — — 316 316 — 
Foreign government bonds150 — — 150 — 150 
Total$20,930 $— $(17)$20,913 $1,695 $19,218 
The amortized cost and estimated fair value of cash equivalents and marketable securities as of January 29, 2023 and January 30, 2022 are shown below by contractual maturity.
 January 29, 2023January 30, 2022
 Amortized
Cost
Estimated
Fair Value
Amortized
Cost
Estimated
Fair Value
 (In millions)
Less than one year$9,738 $9,708 $16,346 $16,343 
Due in 1 - 5 years3,374 3,347 4,584 4,570 
Total$13,112 $13,055 $20,930 $20,913 
Schedule of Marketable Securities in a Continuous Unrealized Loss Position
The following tables provide the breakdown of unrealized losses as of January 29, 2023 and January 30, 2022, aggregated by investment category and length of time that individual securities have been in a continuous loss position:
January 29, 2023
 Less than 12 Months12 Months or GreaterTotal
 Estimated Fair ValueGross Unrealized LossEstimated Fair ValueGross Unrealized LossEstimated Fair ValueGross Unrealized Loss
 (In millions)
Debt securities issued by the United States Treasury$2,444 $(21)$1,172 $(23)$3,616 $(44)
Corporate debt securities1,188 (7)696 (5)1,884 (12)
Debt securities issued by United States government agencies1,307 (2)— — 1,307 (2)
Total$4,939 $(30)$1,868 $(28)$6,807 $(58)
January 30, 2022
 Less than 12 Months12 Months or GreaterTotal
 Estimated Fair ValueGross Unrealized LossEstimated Fair ValueGross Unrealized LossEstimated Fair ValueGross Unrealized Loss
 (In millions)
Debt securities issued by the United States Treasury$5,292 $(14)$— $— $5,292 $(14)
Corporate debt securities2,445 (3)19 — 2,464 (3)
Total$7,737 $(17)$19 $— $7,756 $(17)
v3.22.4
Fair Value of Financial Assets and Liabilities (Tables)
12 Months Ended
Jan. 29, 2023
Fair Value Disclosures [Abstract]  
Schedule of Fair Value of Financial Assets and Liabilities
Fair Value at
Pricing CategoryJanuary 29, 2023January 30, 2022
(In millions)
Assets
Cash equivalents and marketable securities:
Money market fundsLevel 1$1,777 $316 
Corporate debt securitiesLevel 2$4,797 $9,974 
Debt securities issued by the United States TreasuryLevel 2$4,142 $7,300 
Debt securities issued by United States government agenciesLevel 2$1,834 $1,612 
Certificates of depositLevel 2$365 $1,561 
Foreign government bondsLevel 2$140 $150 
Other assets (Investment in non-affiliated entities):
Publicly-held equity securities (1)Level 1$11 $58 
Privately-held equity securitiesLevel 3$288 $208 
Liabilities (2)
0.309% Notes Due 2023
Level 2$1,230 $1,236 
0.584% Notes Due 2024
Level 2$1,185 $1,224 
3.20% Notes Due 2026
Level 2$966 $1,055 
1.55% Notes Due 2028
Level 2$1,099 $1,200 
2.85% Notes Due 2030
Level 2$1,364 $1,542 
2.00% Notes Due 2031
Level 2$1,044 $1,200 
3.50% Notes Due 2040
Level 2$870 $1,066 
3.50% Notes Due 2050
Level 2$1,637 $2,147 
3.70% Notes Due 2060
Level 2$410 $551 
(1)    Unrealized losses of $61 million from investments in publicly-traded equity securities were recorded in other income (expense), net, in fiscal year 2023. Unrealized gains of $48 million from an investment in a publicly-traded equity security were recorded in other income (expense), net, in fiscal year 2022.
(2)    These liabilities are carried on our Consolidated Balance Sheets at their original issuance value, net of unamortized debt discount and issuance costs.
v3.22.4
Balance Sheet Components (Tables)
12 Months Ended
Jan. 29, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Inventory
Certain balance sheet components are as follows:
 January 29,
2023
January 30,
2022
(In millions)
Inventories (1):
Raw materials$2,430 $791 
Work in-process466 692 
Finished goods2,263 1,122 
Total inventories$5,159 $2,605 
(1) In fiscal years 2023 and 2022, we recorded an inventory reserve expense of approximately $1.04 billion and $173 million in cost of revenue, respectively.
Schedule of Property and Equipment
 January 29,
2023
January 30,
2022
Estimated
Useful Life
(In millions)(In years)
Property and Equipment:
Land$218 $218 (A)
Buildings, leasehold improvements, and furniture1,598 874 (B)
Equipment, compute hardware, and software4,303 2,852 
3-5
Construction in process382 737 (C)
Total property and equipment, gross6,501 4,681  
Accumulated depreciation and amortization(2,694)(1,903) 
Total property and equipment, net$3,807 $2,778  
(A)Land is a non-depreciable asset.
(B)The estimated useful lives of our buildings are up to thirty years. Leasehold improvements and finance leases are amortized based on the lesser of either the asset’s estimated useful life or the expected lease term.
(C)Construction in process represents assets that are not available for their intended use as of the balance sheet date.
Schedule of Other Assets
 January 29,
2023
January 30,
2022
Other assets:(In millions)
Prepaid supply agreements$2,989 $1,747 
Prepaid royalties387 409 
Investment in non-affiliated entities299 266 
Advanced consideration for acquisition (1)— 1,353 
Other145 66 
Total other assets$3,820 $3,841 
(1)Refer to Note 2 - Business Combination for further details on the Arm acquisition.
Schedule of Accrued and Other Current Liabilities
 January 29,
2023
January 30,
2022
(In millions)
Accrued and Other Current Liabilities:
Customer program accruals$1,196 $1,000 
Excess inventory purchase obligations (1)954 196 
Accrued payroll and related expenses530 409 
Taxes payable467 132 
Deferred revenue (2)354 300 
Operating leases176 144 
Other443 371 
Total accrued and other current liabilities$4,120 $2,552 
(1)In fiscal years 2023 and 2022, we recorded an expense of approximately $1.13 billion and $181 million, respectively, in cost of revenue for inventory purchase obligations in excess of our current demand projections, and cancellation and underutilization penalties.
(2)Deferred revenue primarily includes customer advances and deferrals related to license and development arrangements, support for hardware and software, and cloud services.
Schedule of Other Long-term Liabilities
 January 29,
2023
January 30,
2022
(In millions)
Other Long-Term Liabilities:
Income tax payable (1)$1,204 $980 
Deferred income tax247 245 
Deferred revenue (2)218 202 
Licenses payable181 77 
Other63 49 
Total other long-term liabilities$1,913 $1,553 
(1)Income tax payable is comprised of the long-term portion of the one-time transition tax payable, unrecognized tax benefits, and related interest and penalties.
(2)Deferred revenue primarily includes deferrals related to support for hardware and software.
Schedule of Changes in Deferred Revenue
The following table shows the changes in deferred revenue during fiscal years 2023 and 2022.
 January 29,
2023
January 30,
2022
(In millions)
Balance at beginning of period$502 $451 
Deferred revenue added during the period830 821 
Addition due to business combinations— 
Revenue recognized during the period(760)(778)
Balance at end of period$572 $502 
v3.22.4
Derivative Financial Instruments (Tables)
12 Months Ended
Jan. 29, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Notional Value of Our Foreign Currency Forward Contracts Outstanding
The table below presents the notional value of our foreign currency forward contracts outstanding as of January 29, 2023 and January 30, 2022:
January 29,
2023
January 30,
2022
 (In millions)
Designated as cash flow hedges$1,128 $1,023 
Non-designated hedges$366 $408 
v3.22.4
Debt (Tables)
12 Months Ended
Jan. 29, 2023
Debt Disclosure [Abstract]  
Schedule of Long-term Debt
The carrying value of the Notes, the calendar year of maturity, and the associated interest rates were as follows:
 Expected
Remaining Term (years)
Effective
Interest Rate
January 29,
2023
January 30,
2022
   (In millions)
0.309% Notes Due 2023
0.40.41%$1,250 $1,250 
0.584% Notes Due 2024
1.40.66%1,250 1,250 
3.20% Notes Due 2026
3.63.31%1,000 1,000 
1.55% Notes Due 2028
5.41.64%1,250 1,250 
2.85% Notes Due 2030
7.22.93%1,500 1,500 
2.00% Notes Due 2031
8.42.09%1,250 1,250 
3.50% Notes Due 2040
17.23.54%1,000 1,000 
3.50% Notes Due 2050
27.23.54%2,000 2,000 
3.70% Notes Due 2060
37.23.73%500 500 
Unamortized debt discount and issuance costs  (47)(54)
Net carrying amount  10,953 10,946 
Less short-term portion(1,250)— 
Total long-term portion$9,703 $10,946 
v3.22.4
Commitments and Contingencies (Tables)
12 Months Ended
Jan. 29, 2023
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Purchase Obligation, Fiscal Year Maturity
Total future purchase commitments as of January 29, 2023, are as follows:
Commitments
 (In millions)
Fiscal Year: 
2024$5,230 
2025983 
2026679 
2027622 
2028296 
2029 and thereafter253 
Total$8,063 
Schedule of Product Warranty Activity The estimated product returns and estimated product warranty activity consisted of the following:
Year Ended
January 29,January 30,January 31,
202320222021
(In millions)
Balance at beginning of period
$46 $22 $15 
Additions
145 4028
Utilization
(109)(16)(21)
Balance at end of period
$82 $46 $22 
v3.22.4
Income Taxes (Tables)
12 Months Ended
Jan. 29, 2023
Income Tax Disclosure [Abstract]  
Schedule of Income Tax Expense (benefit)
The income tax expense (benefit) applicable to income before income taxes consists of the following:
 Year Ended
 January 29,
2023
January 30,
2022
January 31,
2021
 (In millions)
Current income taxes:   
Federal$1,703 $482 $197 
State46 42 
Foreign228 71 161 
Total current1,977 595 359 
Deferred taxes:   
Federal(2,165)(420)(246)
Foreign14 (36)
Total deferred(2,164)(406)(282)
Income tax expense (benefit)$(187)$189 $77 
Schedule of Income Before Income Tax Income before income tax consists of the following:
 Year Ended
 January 29,
2023
January 30,
2022
January 31,
2021
 (In millions)
U.S.$3,477 $8,446 $1,437 
Foreign704 1,495 2,972 
Income before income tax$4,181 $9,941 $4,409 
Schedule of Effective Income Tax Rate Reconciliation The income tax expense (benefit) differs from the amount computed by applying the U.S. federal statutory rate of 21% to income before income taxes as follows:
 Year Ended
 January 29,
2023
January 30,
2022
January 31,
2021
 (In millions, except percentages)
Tax expense computed at federal statutory rate$878 21.0 %$2,088 21.0 %$926 21.0 %
Expense (benefit) resulting from:
Acquisition termination cost261 6.2 %— — %— — %
State income taxes, net of federal tax effect50 1.2 %42 0.4 %10 0.2 %
Foreign-derived intangible income(739)(17.7)%(520)(5.2)%— — %
Stock-based compensation(309)(7.4)%(337)(3.4)%(136)(3.1)%
U.S. federal research and development tax credit(278)(6.6)%(289)(2.9)%(173)(3.9)%
Foreign tax rate differential(83)(2.0)%(497)(5.0)%(561)(12.7)%
IP domestication— — %(244)(2.5)%— — %
Other33 0.8 %(54)(0.5)%11 0.2 %
Income tax expense (benefit)$(187)(4.5)%$189 1.9 %$77 1.7 %
Schedule of Deferred Tax Assets and Liabilities
The tax effect of temporary differences that gives rise to significant portions of the deferred tax assets and liabilities are presented below: 
 January 29,
2023
January 30,
2022
 (In millions)
Deferred tax assets: 
Capitalized research and development expenditure (1)$1,859 $508 
Research and other tax credit carryforwards951 798 
GILTI deferred tax assets800 378 
Accruals and reserves, not currently deductible for tax purposes686 258 
Net operating loss and capital loss carryforwards409 118 
Operating lease liabilities193 125 
Stock-based compensation99 86 
Property, equipment and intangible assets66 22 
Other deferred tax assets91 22 
Gross deferred tax assets5,154 2,315 
Less valuation allowance(1,484)(907)
Total deferred tax assets3,670 1,408 
Deferred tax liabilities:  
Unremitted earnings of foreign subsidiaries(228)(150)
Operating lease assets(179)(113)
Acquired intangibles(115)(169)
Gross deferred tax liabilities(522)(432)
Net deferred tax asset (2)$3,148 $976 
(1) Capitalized research and development deferred tax assets were previously included in Property, equipment and intangible assets.
(2) Net deferred tax asset includes long-term deferred tax assets of $3.40 billion and $1.22 billion and long-term deferred tax liabilities of $247 million and $245 million for fiscal years 2023 and 2022, respectively. Long-term deferred tax liabilities are included in other long-term liabilities on our Consolidated Balance Sheets.
Schedule of Gross Unrecognized Tax Benefits
A reconciliation of gross unrecognized tax benefits is as follows:
 January 29,
2023
January 30,
2022
January 31,
2021
 (In millions)
Balance at beginning of period$1,013 $776 $583 
Increases in tax positions for current year268 246 158 
Increases in tax positions for prior years14 60 
Decreases in tax positions for prior years(15)(4)(11)
Settlements(9)(8)(5)
Lapse in statute of limitations(20)(11)(9)
Balance at end of period$1,238 $1,013 $776 
v3.22.4
Segment Information (Tables)
12 Months Ended
Jan. 29, 2023
Segment Reporting [Abstract]  
Schedule of Reportable Segments
 Compute & NetworkingGraphicsAll OtherConsolidated
(In millions)
Year Ended January 29, 2023:
   
Revenue$15,068 $11,906 $— $26,974 
Operating income (loss)$5,083 $4,552 $(5,411)$4,224 
Year Ended January 30, 2022:
   
Revenue$11,046 $15,868 $— $26,914 
Operating income (loss)$4,598 $8,492 $(3,049)$10,041 
Year Ended January 31, 2021:
   
Revenue$6,841 $9,834 $— $16,675 
Operating income (loss)$2,548 $4,612 $(2,628)$4,532 
Year Ended
January 29,
2023
January 30,
2022
January 31,
2021
(In millions)
Reconciling items included in "All Other" category:
Stock-based compensation expense$(2,710)$(2,004)$(1,397)
Acquisition termination cost(1,353)— — 
Acquisition-related and other costs(674)(636)(836)
Unallocated cost of revenue and operating expenses(595)(399)(357)
Restructuring costs and other(54)— — 
IP-related and legal settlement costs(23)(10)(38)
Contributions(2)— — 
Total$(5,411)$(3,049)$(2,628)
Schedule of Revenue by Geographic Regions
 Year Ended
 January 29,
2023
January 30,
2022
January 31,
2021
Revenue:(In millions)
United States$8,292 $4,349 $3,214 
Taiwan6,986 8,544 4,531 
China (including Hong Kong)5,785 7,111 3,886 
Other countries5,911 6,910 5,044 
Total revenue$26,974 $26,914 $16,675 
Schedule of Revenue by Specialized Markets
The following table summarizes information pertaining to our revenue by each of the specialized markets we serve:
 Year Ended
 January 29,
2023
January 30,
2022
January 31,
2021
Revenue:(In millions)
Data Center$15,005 $10,613 $6,696 
Gaming9,067 12,462 7,759 
Professional Visualization1,544 2,111 1,053 
Automotive903 566 536 
OEM & Other455 1,162 631 
Total revenue$26,974 $26,914 $16,675 
Schedule of Long-Lived Assets by Geographic Region
The following table presents summarized information for long-lived assets by country. Long-lived assets consist of property and equipment and exclude other assets, operating lease assets, goodwill, and intangible assets.
 January 29,
2023
January 30,
2022
Long-lived assets:(In millions)
United States$2,587 $2,023 
Taiwan702 379 
Israel283 185 
Other countries235 191 
Total long-lived assets$3,807 $2,778 
v3.22.4
Organization and Summary of Significant Accounting Policies (Details) - USD ($)
$ in Millions
1 Months Ended 12 Months Ended
Jan. 29, 2023
Feb. 24, 2023
Jan. 29, 2024
Jan. 29, 2023
Jan. 30, 2022
Jan. 31, 2021
Property, Plant and Equipment [Line Items]            
Operating income (loss)       $ 4,224 $ 10,041 $ 4,532
Deferred tax assets, valuation allowance $ 1,484     $ 1,484 $ 907  
Forecast            
Property, Plant and Equipment [Line Items]            
Operating income (loss)     $ 133      
Storage and Net work Equipment            
Property, Plant and Equipment [Line Items]            
Property, plant & equipment, useful life 3 years          
Buildings            
Property, Plant and Equipment [Line Items]            
Property, plant & equipment, useful life       30 years    
Minimum            
Property, Plant and Equipment [Line Items]            
Property, plant & equipment, useful life       3 years    
Warranty liability, term       1 year    
Intangible assets, useful life       1 year    
Maximum            
Property, Plant and Equipment [Line Items]            
Property, plant & equipment, useful life       5 years    
Warranty liability, term       3 years    
Intangible assets, useful life       20 years    
Subsequent Event | Minimum | Storage and Net work Equipment            
Property, Plant and Equipment [Line Items]            
Property, plant & equipment, useful life   4 years        
Subsequent Event | Minimum | Assembling and Testing Equipment            
Property, Plant and Equipment [Line Items]            
Property, plant & equipment, useful life   5 years        
Subsequent Event | Maximum | Storage and Net work Equipment            
Property, Plant and Equipment [Line Items]            
Property, plant & equipment, useful life   5 years        
Subsequent Event | Maximum | Assembling and Testing Equipment            
Property, Plant and Equipment [Line Items]            
Property, plant & equipment, useful life   7 years        
v3.22.4
Business Combination - Termination of the Arm Share Purchase Agreement, Additional Information (Details)
$ in Millions
12 Months Ended
Jan. 29, 2023
USD ($)
Arm Limited  
Business Acquisition [Line Items]  
Transaction costs $ 1,350
v3.22.4
Business Combination - Acquisition of Mellanox Technologies, Additional Information (Details) - Mellanox Technologies, Ltd - USD ($)
$ in Millions
1 Months Ended 12 Months Ended
Apr. 30, 2020
Jan. 31, 2021
Apr. 27, 2020
Business Acquisition [Line Items]      
Merger agreement price $ 7,134    
Transaction costs   $ 28  
IPR&D     $ 630
Fair value adjustment, inventory   $ 161  
Revenue | Revenue Stream Concentration Risk      
Business Acquisition [Line Items]      
Concentration risk (as percent)   10.00%  
v3.22.4
Business Combination - Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
1 Months Ended
Apr. 30, 2020
Jan. 29, 2023
Jan. 30, 2022
Apr. 27, 2020
Allocation        
Goodwill   $ 4,372 $ 4,349  
Mellanox Technologies, Ltd        
Purchase Price        
Total cash consideration $ 7,049      
Fair value of Mellanox equity awards assumed by NVIDIA 85      
Total purchase consideration 7,134      
Allocation        
Cash and cash equivalents 115      
Marketable securities 699      
Accounts receivable, net 216      
Inventories 320      
Prepaid expenses and other assets 179      
Property and equipment, net 144      
Goodwill 3,431      
Intangible assets 2,970     $ 2,970
Accounts payable (136)      
Accrued and other current liabilities (236)      
Income tax liability (191)      
Deferred income tax liability (258)      
Other long-term liabilities (119)      
Net assets acquired (liabilities assumed) $ 7,134      
Merger agreement price (in dollars per share) $ 125.00      
Mellanox Technologies, Ltd | Mellanox Technologies, Ltd        
Allocation        
Business combination, shares issued (in shares) 56,000      
Mellanox Technologies, Ltd | Equity awards        
Purchase Price        
Total cash consideration $ 16      
Mellanox Technologies, Ltd | Employee Stock Option | Mellanox Technologies, Ltd        
Allocation        
Acquiree stock options settled in cash (in shares) 249      
Mellanox Technologies, Ltd | Ordinary shares        
Purchase Price        
Total cash consideration $ 7,033      
v3.22.4
Business Combination - Intangible Assets Acquired (Details) - Mellanox Technologies, Ltd - USD ($)
$ in Millions
Apr. 27, 2020
Apr. 30, 2020
Acquired Finite-Lived Intangible Assets [Line Items]    
Total identified finite-lived intangible assets $ 2,340  
IPR&D 630  
Total identified intangible assets 2,970 $ 2,970
Developed Technology    
Acquired Finite-Lived Intangible Assets [Line Items]    
Total identified finite-lived intangible assets $ 1,640  
Useful Lives 5 years  
Customer relationships    
Acquired Finite-Lived Intangible Assets [Line Items]    
Total identified finite-lived intangible assets $ 440  
Useful Lives 3 years  
Order backlog    
Acquired Finite-Lived Intangible Assets [Line Items]    
Total identified finite-lived intangible assets $ 190  
Trade names    
Acquired Finite-Lived Intangible Assets [Line Items]    
Total identified finite-lived intangible assets $ 70  
Useful Lives 5 years  
v3.22.4
Business Combination - Pro Forma Information (Details)
$ in Millions
12 Months Ended
Jan. 31, 2021
USD ($)
Business Combination and Asset Acquisition [Abstract]  
Revenue $ 17,104
Net income $ 4,757
v3.22.4
Leases - Schedule of Future Minimum Lease Payments (Details) - USD ($)
$ in Millions
Jan. 29, 2023
Jan. 30, 2022
Leases [Abstract]    
2024 $ 220  
2025 198  
2026 180  
2027 166  
2028 144  
2029 and thereafter 323  
Total 1,231  
Less imputed interest 153  
Present value of net future minimum lease payments $ 1,078  
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Accrued and other current liabilities Accrued and other current liabilities
Less short-term operating lease liabilities $ 176 $ 144
Long-term operating lease liabilities $ 902 $ 741
v3.22.4
Leases - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 29, 2023
Jan. 30, 2022
Jan. 31, 2021
Lessee, Lease, Description [Line Items]      
Lease not yet commenced, undiscounted amount $ 463    
Operating lease expense $ 193 $ 168 $ 145
Weighted average remaining lease term - operating leases 6 years 9 months 18 days 7 years 1 month 6 days  
Weighted average discount rate - operating leases 3.21% 2.51%  
Minimum      
Lessee, Lease, Description [Line Items]      
Lease not yet commenced, term of contract 2 years    
Maximum      
Lessee, Lease, Description [Line Items]      
Lease not yet commenced, term of contract 8 years    
v3.22.4
Leases - Schedule of other lease information (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 29, 2023
Jan. 30, 2022
Jan. 31, 2021
Leases [Abstract]      
Operating cash flows used for operating leases $ 184 $ 154 $ 141
Operating lease assets obtained in exchange for lease obligations $ 358 $ 266 $ 200
v3.22.4
Stock-Based Compensation - Schedule of Stock-Based Compensation Expense (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 29, 2023
Jan. 30, 2022
Jan. 31, 2021
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Stock-based compensation expense $ 2,710 $ 2,004 $ 1,397
Cost of revenue      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Stock-based compensation expense 138 141 88
Research and development      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Stock-based compensation expense 1,892 1,298 860
Sales, general and administrative      
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]      
Stock-based compensation expense $ 680 $ 565 $ 449
v3.22.4
Stock-Based Compensation - Summary of Equity Awards (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
12 Months Ended
Jan. 29, 2023
Jan. 30, 2022
Jan. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Awards granted (in shares) 25    
Weighted average grant date fair value (in dollars per share) $ 183.72    
Summary of unearned SBC expense      
Unearned stock-based compensation expense $ 6,560    
RSUs, PSUs and Market-based PSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Awards granted (in shares) 25 18 36
Estimated total grant-date fair value $ 4,505 $ 3,492 $ 2,764
Weighted average grant date fair value (in dollars per share) $ 183.72 $ 190.69 $ 76.81
Summary of unearned SBC expense      
Estimated weighted average amortization period 2 years 7 months 6 days    
Employee Stock Purchase Plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Awards granted (in shares) 3 5 4
Weighted average price (in dollars per share) $ 122.54 $ 56.36 $ 34.80
Weighted average grant date fair value (in dollars per share) $ 51.87 $ 23.24 $ 16.91
Summary of unearned SBC expense      
Estimated weighted average amortization period 1 year    
Fair Value Assumptions      
Risk free interest rate, minimum 0.00% 0.00% 0.10%
Risk free interest rate, maximum 4.60% 0.50% 1.60%
Volatility rate, minimum 43.00% 20.00% 26.00%
Volatility rate, maximum 72.00% 58.00% 89.00%
Dividend yield 10.00% 0.10%  
Employee Stock Purchase Plan | Minimum      
Fair Value Assumptions      
Weighted average expected life (in years) 1 month 6 days 1 month 6 days 1 month 6 days
Dividend yield     0.10%
Employee Stock Purchase Plan | Maximum      
Fair Value Assumptions      
Weighted average expected life (in years) 2 years 2 years 2 years
Dividend yield     0.30%
v3.22.4
Stock-Based Compensation - Narrative (Details)
$ / shares in Units, shares in Millions, $ in Millions
12 Months Ended
Jan. 29, 2023
USD ($)
period
$ / shares
shares
Jan. 30, 2022
USD ($)
shares
Jan. 31, 2021
USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of shares may be issued under the Restated 2007 Plan (in shares) 47    
Outstanding stock options subject to exercise (in shares) 2    
Number of shares available for grant (in shares) 160 131  
Employee stock purchase plan, offering period duration 24 months    
Employee stock purchase plan, number of purchase periods in offering period | period 4    
Employee stock purchase plan, purchase period duration 6 months    
Exercisable options, total intrinsic value | $ $ 410    
Outstanding options, total intrinsic value | $ $ 410    
Exercisable options, average exercise price (in dollars per share) | $ / shares $ 3.79    
Outstanding options, average exercise price (in dollars per share) | $ / shares $ 3.79    
Exercisable options, average remaining term 6 months    
Outstanding options, average remaining term 6 months    
Total intrinsic value of options exercised during the period | $ $ 642 $ 741 $ 521
RSUs, PSUs and Market-based PSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of shares available for grant (in shares) 160    
Total fair value of units as of respective vesting dates | $ $ 4,270 $ 5,560 $ 2,670
Restricted Stock Units (RSUs) | Tranche One      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period 4 years    
Vesting rights (as percent) 25.00%    
Quarterly vesting schedule - RSUs and PSUs (as percent) 6.25%    
Restricted Stock Units (RSUs) | Tranche Two      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period 3 years    
Vesting rights (as percent) 40.00%    
Quarterly vesting schedule - RSUs and PSUs (as percent) 7.50%    
Restricted Stock Units (RSUs) | Tranche Three      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period 4 years    
Quarterly vesting schedule - RSUs and PSUs (as percent) 6.25%    
Performance Stock Units      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period 4 years    
Vesting rights (as percent) 25.00%    
Quarterly vesting schedule - RSUs and PSUs (as percent) 6.25%    
Market-based PSUs      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Award vesting period 3 years    
Maximum issuable shares of Market-based PSUs, percentage (as percent) 100.00%    
Employee Stock Purchase Plan      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Maximum employee subscription rate (as percent) 15.00%    
Purchase price of ESPP (as percent) 85.00%    
Shares reserved for future issuance (in shares) 230    
v3.22.4
Stock-Based Compensation - Equity Incentive Plans (Details)
shares in Millions
12 Months Ended
Jan. 29, 2023
$ / shares
shares
Number of Shares  
RSUs, PSUs and Market-based PSUs, outstanding, beginning balance (in shares) | shares 46
RSUs, PSUs and Market-based PSUs, granted (in shares) | shares 25
RSUs, PSUs and Market-based PSUs, vested (in shares) | shares (24)
RSUs, PSUs and Market-based PSUs, canceled and forfeited (in shares) | shares (2)
RSUs, PSUs and Market-based PSUs, outstanding, ending balance (in shares) | shares 45
Vested and expected to vest, RSUs, PSUs and Market-based PSUs (in shares) | shares 45
Weighted Average Grant-Date Fair Value  
PSUs and Market-based PSUs, weighted average grant date fair value, beginning balance (in USD per share) | $ / shares $ 114.19
PSUs and Market-based PSUs, weighted average grant date fair value, granted (in USD per share) | $ / shares 183.72
PSUs and Market-based PSUs, weighted average grant date fair value, vested (in USD per share) | $ / shares 100.06
PSUs and Market-based PSUs, weighted average grant date fair value, canceled and forfeited (in USD per share) | $ / shares 141.17
PSUs and Market-based PSUs, weighted average grant date fair value, ending balance (in USD per share) | $ / shares 158.45
Vested and expected to vest, RSUs, PSUs and Market-based PSUs, weighted average grant date fair value (in USD per share) | $ / shares $ 158.35
v3.22.4
Net Income Per Share (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
12 Months Ended
Jan. 29, 2023
Jan. 30, 2022
Jan. 31, 2021
Numerator:      
Net income $ 4,368 $ 9,752 $ 4,332
Denominator:      
Basic weighted average shares (in shares) 2,487 2,496 2,467
Dilutive impact of outstanding equity awards (in shares) 20 39 43
Diluted weighted average shares (in shares) 2,507 2,535 2,510
Net income per share:      
Basic (in USD per share) $ 1.76 $ 3.91 $ 1.76
Diluted (in USD per share) $ 1.74 $ 3.85 $ 1.73
Equity awards excluded from diluted net income per share because their effect would have been anti-dilutive (in shares) 40 21 12
v3.22.4
Goodwill (Details) - USD ($)
12 Months Ended
Jan. 29, 2023
Jan. 30, 2022
Jan. 31, 2021
Goodwill [Line Items]      
Goodwill $ 4,372,000,000 $ 4,349,000,000  
Goodwill acquired during period 23,000,000    
Goodwill impairment loss 0 0 $ 0
Compute & Networking      
Goodwill [Line Items]      
Goodwill 4,000,000,000 3,990,000,000  
Changes in goodwill 14,000,000    
Graphics      
Goodwill [Line Items]      
Goodwill 370,000,000 $ 361,000,000  
Changes in goodwill $ 9,000,000    
v3.22.4
Amortizable Intangible Assets (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 29, 2023
Jan. 30, 2022
Jan. 31, 2021
May 01, 2022
Finite-Lived Intangible Assets [Line Items]        
Gross Carrying Amount $ 3,539 $ 3,507    
Accumulated Amortization (1,863) (1,168)    
Net  Carrying Amount 1,676 2,339    
Amortization expense 699 563 $ 612  
Future amortization expense associated with intangible assets        
Fiscal 2024 602      
Fiscal 2025 541      
Fiscal 2026 247      
Fiscal 2027 142      
Fiscal 2028 35      
Fiscal 2029 and thereafter 109      
Acquisition-related intangible assets        
Finite-Lived Intangible Assets [Line Items]        
Gross Carrying Amount 3,093 3,061    
Accumulated Amortization (1,614) (947)    
Net  Carrying Amount 1,479 2,114    
Patents and licensed technology        
Finite-Lived Intangible Assets [Line Items]        
Gross Carrying Amount 446 446    
Accumulated Amortization (249) (221)    
Net  Carrying Amount $ 197 $ 225    
In process research and development        
Finite-Lived Intangible Assets [Line Items]        
Gross Carrying Amount       $ 630
v3.22.4
Cash Equivalents and Marketable Securities (Details) - USD ($)
$ in Millions
Jan. 29, 2023
Jan. 30, 2022
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost $ 13,112 $ 20,930
Unrealized Gain 1 0
Unrealized Loss (58) (17)
Estimated Fair Value 13,055 20,913
Cash Equivalents 3,148 1,695
Marketable Securities 9,907 19,218
Corporate debt securities    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 4,809 9,977
Unrealized Gain 0 0
Unrealized Loss (12) (3)
Estimated Fair Value 4,797 9,974
Cash Equivalents 1,087 1,102
Marketable Securities 3,710 8,872
Debt securities issued by the United States Treasury    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 4,185 7,314
Unrealized Gain 1 0
Unrealized Loss (44) (14)
Estimated Fair Value 4,142 7,300
Cash Equivalents 0 0
Marketable Securities 4,142 7,300
Debt securities issued by United States government agencies    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 1,836 1,612
Unrealized Gain 0 0
Unrealized Loss (2) 0
Estimated Fair Value 1,834 1,612
Cash Equivalents 50 256
Marketable Securities 1,784 1,356
Money market funds    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 1,777 316
Unrealized Gain 0 0
Unrealized Loss 0 0
Estimated Fair Value 1,777 316
Cash Equivalents 1,777 316
Marketable Securities 0 0
Certificates of deposit    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 365 1,561
Unrealized Gain 0 0
Unrealized Loss 0 0
Estimated Fair Value 365 1,561
Cash Equivalents 134 21
Marketable Securities 231 1,540
Foreign government bonds    
Debt Securities, Available-for-sale [Line Items]    
Amortized Cost 140 150
Unrealized Gain 0 0
Unrealized Loss 0 0
Estimated Fair Value 140 150
Cash Equivalents 100 0
Marketable Securities $ 40 $ 150
v3.22.4
Cash Equivalents and Marketable Securities - Unrealized Losses Aggregated by Investment Category (Details) - USD ($)
$ in Millions
Jan. 29, 2023
Jan. 30, 2022
Estimated Fair Value    
Less than 12 Months $ 4,939 $ 7,737
12 Months or Greater 1,868 19
Total 6,807 7,756
Gross Unrealized Loss    
Less than 12 Months (30) (17)
12 Months or Greater (28) 0
Total (58) (17)
Debt securities issued by the United States Treasury    
Estimated Fair Value    
Less than 12 Months 2,444 5,292
12 Months or Greater 1,172 0
Total 3,616 5,292
Gross Unrealized Loss    
Less than 12 Months (21) (14)
12 Months or Greater (23) 0
Total (44) (14)
Corporate debt securities    
Estimated Fair Value    
Less than 12 Months 1,188 2,445
12 Months or Greater 696 19
Total 1,884 2,464
Gross Unrealized Loss    
Less than 12 Months (7) (3)
12 Months or Greater (5) 0
Total (12) $ (3)
Debt securities issued by United States government agencies    
Estimated Fair Value    
Less than 12 Months 1,307  
12 Months or Greater 0  
Total 1,307  
Gross Unrealized Loss    
Less than 12 Months (2)  
12 Months or Greater 0  
Total $ (2)  
v3.22.4
Cash Equivalents and Marketable Securities - Amortized Cost and Estimated Fair Value of Cash Equivalents and Marketable Securities (Details) - USD ($)
$ in Millions
Jan. 29, 2023
Jan. 30, 2022
Amortized Cost    
Less than one year $ 9,738 $ 16,346
Due in 1 - 5 years 3,374 4,584
Amortized Cost 13,112 20,930
Estimated Fair Value    
Less than one year 9,708 16,343
Due in 1 - 5 years 3,347 4,570
Estimated Fair Value $ 13,055 $ 20,913
v3.22.4
Fair Value of Financial Assets and Liabilities (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 29, 2023
Jan. 30, 2022
Assets    
Cash equivalents and marketable securities $ 13,055 $ 20,913
Investment in non-affiliated entities 299 266
Liabilities    
Unrealized loss recognized during the period $ 61  
Unrealized gain recognized during the period   48
0.309% Notes Due 2023    
Liabilities    
Interest rate (as percent) 0.309%  
0.584% Notes Due 2024    
Liabilities    
Interest rate (as percent) 0.584%  
3.20% Notes Due 2026    
Liabilities    
Interest rate (as percent) 3.20%  
1.55% Notes Due 2028    
Liabilities    
Interest rate (as percent) 1.55%  
2.85% Notes Due 2030    
Liabilities    
Interest rate (as percent) 2.85%  
2.00% Notes Due 2031    
Liabilities    
Interest rate (as percent) 2.00%  
3.50% Notes Due 2040    
Liabilities    
Interest rate (as percent) 3.50%  
3.50% Notes Due 2050    
Liabilities    
Interest rate (as percent) 3.50%  
3.70% Notes Due 2060    
Liabilities    
Interest rate (as percent) 3.70%  
Level 1 | Money market funds    
Assets    
Cash equivalents and marketable securities $ 1,777 316
Level 1 | Publicly-held equity securities    
Assets    
Investment in non-affiliated entities 11 58
Level 2 | 0.309% Notes Due 2023    
Liabilities    
Long-term debt 1,230 1,236
Level 2 | 0.584% Notes Due 2024    
Liabilities    
Long-term debt 1,185 1,224
Level 2 | 3.20% Notes Due 2026    
Liabilities    
Long-term debt 966 1,055
Level 2 | 1.55% Notes Due 2028    
Liabilities    
Long-term debt 1,099 1,200
Level 2 | 2.85% Notes Due 2030    
Liabilities    
Long-term debt 1,364 1,542
Level 2 | 2.00% Notes Due 2031    
Liabilities    
Long-term debt 1,044 1,200
Level 2 | 3.50% Notes Due 2040    
Liabilities    
Long-term debt 870 1,066
Level 2 | 3.50% Notes Due 2050    
Liabilities    
Long-term debt 1,637 2,147
Level 2 | 3.70% Notes Due 2060    
Liabilities    
Long-term debt 410 551
Level 2 | Corporate debt securities    
Assets    
Cash equivalents and marketable securities 4,797 9,974
Level 2 | Debt securities issued by the United States Treasury    
Assets    
Cash equivalents and marketable securities 4,142 7,300
Level 2 | Debt securities issued by United States government agencies    
Assets    
Cash equivalents and marketable securities 1,834 1,612
Level 2 | Certificates of deposit    
Assets    
Cash equivalents and marketable securities 365 1,561
Level 2 | Foreign government bonds    
Assets    
Cash equivalents and marketable securities 140 150
Level 3 | Privately-held equity securities    
Assets    
Investment in non-affiliated entities $ 288 $ 208
v3.22.4
Balance Sheet Components - Inventories (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 29, 2023
Jan. 30, 2022
Inventories (1):    
Raw materials $ 2,430 $ 791
Work in-process 466 692
Finished goods 2,263 1,122
Total inventories 5,159 2,605
Inventory reserves expenses $ 1,040 $ 173
v3.22.4
Balance Sheet Components - Property and Equipment (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 29, 2023
Jan. 30, 2022
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross $ 6,501 $ 4,681
Accumulated depreciation and amortization (2,694) (1,903)
Total property and equipment, net $ 3,807 2,778
Minimum    
Property, Plant and Equipment [Line Items]    
Property, plant & equipment, useful life 3 years  
Maximum    
Property, Plant and Equipment [Line Items]    
Property, plant & equipment, useful life 5 years  
Land    
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross $ 218 218
Buildings, leasehold improvements, and furniture    
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross 1,598 874
Equipment, compute hardware, and software    
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross $ 4,303 2,852
Equipment, compute hardware, and software | Minimum    
Property, Plant and Equipment [Line Items]    
Property, plant & equipment, useful life 3 years  
Equipment, compute hardware, and software | Maximum    
Property, Plant and Equipment [Line Items]    
Property, plant & equipment, useful life 5 years  
Construction in process    
Property, Plant and Equipment [Line Items]    
Total property and equipment, gross $ 382 $ 737
Buildings    
Property, Plant and Equipment [Line Items]    
Property, plant & equipment, useful life 30 years  
v3.22.4
Balance Sheet Components - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 29, 2023
Jan. 30, 2022
Jan. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]      
Depreciation expense $ 844 $ 611 $ 486
Accumulated amortization of lease hold improvements and capital lease 327 265  
Capital expenditures incurred but not yet paid $ 374 $ 258 $ 157
v3.22.4
Balance Sheet Components - Other Assets (Details) - USD ($)
$ in Millions
Jan. 29, 2023
Jan. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Prepaid supply agreements $ 2,989 $ 1,747
Prepaid royalties 387 409
Investment in non-affiliated entities 299 266
Advanced consideration for acquisition 0 1,353
Other 145 66
Other assets $ 3,820 $ 3,841
v3.22.4
Balance Sheet Components - Accrued and Other Current Liabilities (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 29, 2023
Jan. 30, 2022
Jan. 31, 2021
Accrued and Other Current Liabilities:      
Customer program accruals $ 1,196 $ 1,000  
Excess inventory purchase obligations 954 196  
Accrued payroll and related expenses 530 409  
Taxes payable 467 132  
Deferred revenue $ 354 $ 300  
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Accrued and other current liabilities Accrued and other current liabilities  
Operating leases $ 176 $ 144  
Other 443 371  
Accrued and other current liabilities 4,120 2,552  
Cost of revenue 11,618 9,439 $ 6,279
Inventory Purchase Obligations In Excess Of Projections      
Accrued and Other Current Liabilities:      
Cost of revenue $ 1,130 $ 181  
v3.22.4
Balance Sheet Components - Other Long-Term Liabilities (Details) - USD ($)
$ in Millions
Jan. 29, 2023
Jan. 30, 2022
Other Long-Term Liabilities:    
Income tax payable $ 1,204 $ 980
Deferred income tax 247 245
Deferred revenue 218 202
Licenses payable 181 77
Other 63 49
Total other long-term liabilities $ 1,913 $ 1,553
v3.22.4
Balance Sheet Components - Deferred Revenue (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 29, 2023
Jan. 30, 2022
Movement in Deferred Revenue [Roll Forward]    
Balance at beginning of period $ 502 $ 451
Deferred revenue added during the period 830 821
Addition due to business combinations 0 8
Revenue recognized during the period (760) (778)
Balance at end of period $ 572 $ 502
v3.22.4
Balance Sheet Components - Revenue Remaining Performance Obligation (Details)
$ in Millions
Jan. 29, 2023
USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Remaining performance obligation $ 652
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-30  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Remaining performance obligation (as percent) 47.00%
Expected performance period 12 months
v3.22.4
Derivative Financial Instruments (Details) - USD ($)
$ in Millions
Jan. 29, 2023
Jan. 30, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]    
Designated as cash flow hedges $ 1,128 $ 1,023
Non-designated hedges $ 366 $ 408
v3.22.4
Derivative Financial Instruments - Narrative (Details)
12 Months Ended
Jan. 29, 2023
Foreign currency forward contract  
Derivative [Line Items]  
Maximum maturity period 18 months
v3.22.4
Debt - Narrative (Details) - USD ($)
1 Months Ended 12 Months Ended
Jun. 30, 2021
Mar. 31, 2020
Sep. 30, 2016
Jan. 29, 2023
Jan. 30, 2022
Jan. 31, 2021
Debt Instrument [Line Items]            
Proceeds from issuance of bet, net of issuance costs       $ 0 $ 4,977,000,000 $ 4,968,000,000
Repayment of debt       0 1,000,000,000 $ 0
Outstanding commercial paper       0    
Commercial Paper            
Debt Instrument [Line Items]            
Maximum borrowing capacity       $ 575,000,000    
Notes Issued June 2021            
Debt Instrument [Line Items]            
Face amount of debt issued $ 5,000,000,000          
Proceeds from issuance of bet, net of issuance costs $ 4,980,000,000          
Notes Issued March 2020            
Debt Instrument [Line Items]            
Face amount of debt issued   $ 5,000,000,000        
Proceeds from issuance of bet, net of issuance costs   $ 4,970,000,000        
Notes Issued September 2016            
Debt Instrument [Line Items]            
Face amount of debt issued     $ 2,000,000,000      
Proceeds from issuance of bet, net of issuance costs     $ 1,980,000,000      
2.20% Notes Due 2021            
Debt Instrument [Line Items]            
Repayment of debt         $ 1,000,000,000  
Stated interest rate         2.20%  
v3.22.4
Debt - Schedule of Debt (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 29, 2023
Jan. 30, 2022
Debt Instrument [Line Items]    
Unamortized debt discount and issuance costs $ (47) $ (54)
Net carrying amount 10,953 10,946
Less short-term portion (1,250) 0
Long-term debt $ 9,703 10,946
0.309% Notes Due 2023    
Debt Instrument [Line Items]    
Interest rate (as percent) 0.309%  
Expected Remaining Term (years) 4 months 24 days  
Effective Interest Rate (as percent) 0.41%  
Gross carrying amount $ 1,250 1,250
0.584% Notes Due 2024    
Debt Instrument [Line Items]    
Interest rate (as percent) 0.584%  
Expected Remaining Term (years) 1 year 4 months 24 days  
Effective Interest Rate (as percent) 0.66%  
Gross carrying amount $ 1,250 1,250
3.20% Notes Due 2026    
Debt Instrument [Line Items]    
Interest rate (as percent) 3.20%  
Expected Remaining Term (years) 3 years 7 months 6 days  
Effective Interest Rate (as percent) 3.31%  
Gross carrying amount $ 1,000 1,000
1.55% Notes Due 2028    
Debt Instrument [Line Items]    
Interest rate (as percent) 1.55%  
Expected Remaining Term (years) 5 years 4 months 24 days  
Effective Interest Rate (as percent) 1.64%  
Gross carrying amount $ 1,250 1,250
2.85% Notes Due 2030    
Debt Instrument [Line Items]    
Interest rate (as percent) 2.85%  
Expected Remaining Term (years) 7 years 2 months 12 days  
Effective Interest Rate (as percent) 2.93%  
Gross carrying amount $ 1,500 1,500
2.00% Notes Due 2031    
Debt Instrument [Line Items]    
Interest rate (as percent) 2.00%  
Expected Remaining Term (years) 8 years 4 months 24 days  
Effective Interest Rate (as percent) 2.09%  
Gross carrying amount $ 1,250 1,250
3.50% Notes Due 2040    
Debt Instrument [Line Items]    
Interest rate (as percent) 3.50%  
Expected Remaining Term (years) 17 years 2 months 12 days  
Effective Interest Rate (as percent) 3.54%  
Gross carrying amount $ 1,000 1,000
3.50% Notes Due 2050    
Debt Instrument [Line Items]    
Interest rate (as percent) 3.50%  
Expected Remaining Term (years) 27 years 2 months 12 days  
Effective Interest Rate (as percent) 3.54%  
Gross carrying amount $ 2,000 2,000
3.70% Notes Due 2060    
Debt Instrument [Line Items]    
Interest rate (as percent) 3.70%  
Expected Remaining Term (years) 37 years 2 months 12 days  
Effective Interest Rate (as percent) 3.73%  
Gross carrying amount $ 500 $ 500
v3.22.4
Commitments and Contingencies - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended
Oct. 30, 2022
Jul. 31, 2022
Jan. 29, 2023
Jan. 30, 2022
Jan. 31, 2021
Jan. 26, 2020
Supply Commitment [Line Items]            
Supply agreements     $ 810      
Inventory purchase and long-term supply agreements     4,920      
Other purchase obligations     3,140      
Warranty accrual     82 $ 46 $ 22 $ 15
Warranty-related liability (benefit) $ (70) $ 122        
License and Service            
Supply Commitment [Line Items]            
Other purchase obligations     $ 2,230      
v3.22.4
Commitments and Contingencies - Summary of Future Commitments Due by Year (Details)
$ in Millions
Jan. 29, 2023
USD ($)
Fiscal Year:  
2024 $ 5,230
2025 983
2026 679
2027 622
2028 296
2029 and thereafter 253
Total $ 8,063
v3.22.4
Commitments and Contingencies - Schedule of Product Warranty Liabilities (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 29, 2023
Jan. 30, 2022
Jan. 31, 2021
Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]      
Beginning Balance $ 46 $ 22 $ 15
Additions 145 40 28
Utilization (109) (16) (21)
Ending Balance $ 82 $ 46 $ 22
v3.22.4
Income Taxes - Components of Income Tax Expense (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 29, 2023
Jan. 30, 2022
Jan. 31, 2021
Current income taxes:      
Federal $ 1,703 $ 482 $ 197
State 46 42 1
Foreign 228 71 161
Total current 1,977 595 359
Deferred taxes:      
Federal (2,165) (420) (246)
Foreign 1 14 (36)
Total deferred (2,164) (406) (282)
Income tax expense (benefit) (187) 189 77
Income before Income Taxes      
U.S. 3,477 8,446 1,437
Foreign 704 1,495 2,972
Income before income tax $ 4,181 $ 9,941 $ 4,409
v3.22.4
Income Taxes - Income Tax Reconciliation (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 29, 2023
Jan. 30, 2022
Jan. 31, 2021
Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]      
Tax expense computed at federal statutory rate $ 878 $ 2,088 $ 926
Acquisition termination cost 261 0 0
State income taxes, net of federal tax effect 50 42 10
Foreign-derived intangible income (739) (520) 0
Stock-based compensation (309) (337) (136)
U.S. federal research and development tax credit (278) (289) (173)
Foreign tax rate differential (83) (497) (561)
IP domestication 0 (244) 0
Other 33 (54) 11
Income tax expense (benefit) $ (187) $ 189 $ 77
Effective Income Tax Rate Reconciliation, Percent [Abstract]      
Tax expense computed at federal statutory rate 21.00% 21.00% 21.00%
Acquisition termination cost 0.062 0 0
State income taxes, net of federal tax effect 1.20% 0.40% 0.20%
Foreign-derived intangible income (0.177) (0.052) 0
Stock-based compensation (7.40%) (3.40%) (3.10%)
U.S. federal research and development tax credit (6.60%) (2.90%) (3.90%)
Foreign tax rate differential (2.00%) (5.00%) (12.70%)
IP domestication 0 (0.025) 0
Other 0.80% (0.50%) 0.20%
Effective tax rate (as percent) (4.50%) 1.90% 1.70%
v3.22.4
Income Taxes - Deferred Taxes (Details) - USD ($)
$ in Millions
Jan. 29, 2023
Jan. 30, 2022
Deferred tax assets:    
Capitalized research and development expenditure $ 1,859 $ 508
Research and other tax credit carryforwards 951 798
GILTI deferred tax assets 800 378
Accruals and reserves, not currently deductible for tax purposes 686 258
Net operating loss and capital loss carryforwards 409 118
Operating lease liabilities 193 125
Stock-based compensation 99 86
Property, equipment and intangible assets 66 22
Other deferred tax assets 91 22
Gross deferred tax assets 5,154 2,315
Less valuation allowance (1,484) (907)
Total deferred tax assets 3,670 1,408
Deferred tax liabilities:    
Unremitted earnings of foreign subsidiaries (228) (150)
Operating lease assets (179) (113)
Acquired intangibles (115) (169)
Gross deferred tax liabilities (522) (432)
Net deferred tax asset 3,148 976
Deferred tax assets, noncurrent    
Deferred tax assets:    
Gross deferred tax assets 3,400 1,220
Other long-term liabilities    
Deferred tax liabilities:    
Gross deferred tax liabilities $ (247) $ (245)
v3.22.4
Income Taxes - Narrative (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 29, 2023
Jan. 31, 2021
Jan. 26, 2020
Jan. 30, 2022
Income Tax Contingency [Line Items]        
Deferred tax assets, valuation allowance $ 1,484     $ 907
Unrecognized tax benefits that would affect effective tax rate 770      
Interest and taxes recognized related to unrecognized tax benefits 33 $ 14 $ 7  
Interest and penalties accrued 95     $ 59
Mellanox Technologies, Ltd | Israel        
Income Tax Contingency [Line Items]        
Undistributed earnings of foreign subsidiaries 1,050      
Mellanox Technologies, Ltd | United Kingdom        
Income Tax Contingency [Line Items]        
Undistributed earnings of foreign subsidiaries 245      
Federal        
Income Tax Contingency [Line Items]        
Net operating loss carryforwards 363      
Research tax credit carryforwards 26      
Federal | Capital Loss Carryforward        
Income Tax Contingency [Line Items]        
Federal capital loss carryforwards 1,380      
Foreign Country        
Income Tax Contingency [Line Items]        
Net operating loss carryforwards 329      
State and Local Jurisdiction        
Income Tax Contingency [Line Items]        
Net operating loss carryforwards 329      
Research tax credit carryforwards 1,490      
California        
Income Tax Contingency [Line Items]        
Research tax credit carryforwards 1,410      
Other states        
Income Tax Contingency [Line Items]        
Research tax credit carryforwards $ 83      
v3.22.4
Income Taxes - Unrecognized Tax Benefits (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 29, 2023
Jan. 30, 2022
Jan. 31, 2021
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]      
Balance at beginning of period $ 1,013 $ 776 $ 583
Increases in tax positions for current year 268 246 158
Increases in tax positions for prior years 1 14 60
Decreases in tax positions for prior years (15) (4) (11)
Settlements (9) (8) (5)
Lapse in statute of limitations (20) (11) (9)
Balance at end of period 1,238 $ 1,013 $ 776
Unrecognized tax benefits that would affect effective tax rate $ 770    
v3.22.4
Shareholders' Equity (Details) - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Jan. 29, 2023
Jan. 30, 2022
Jan. 31, 2021
Equity, Class of Treasury Stock [Line Items]      
Number of share repurchased (in shares) 63    
Shares repurchased $ 10,039    
Aggregate number of shares repurchased under stock repurchase program (in shares) 1,100    
Aggregated cost of shares repurchased $ 17,120    
Remaining authorized shares repurchase amount 7,230    
Dividends paid 398 $ 399 $ 395
Retirement of treasury stock (in shares)   349  
Retirement of treasury stock   $ 0  
Additional Paid-in Capital      
Equity, Class of Treasury Stock [Line Items]      
Shares repurchased 4    
Retirement of treasury stock   20  
Retained Earnings      
Equity, Class of Treasury Stock [Line Items]      
Shares repurchased $ 10,034    
Retirement of treasury stock   $ 12,026  
v3.22.4
Employee Retirement Plans (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 29, 2023
Jan. 30, 2022
Jan. 31, 2021
Retirement Benefits [Abstract]      
Defined contribution plan costs $ 227 $ 168 $ 120
v3.22.4
Segment Information - Narrative (Details) - segment
12 Months Ended
Jan. 29, 2023
Jan. 30, 2022
Segment Reporting Information [Line Items]    
Number of reportable segments 2  
Significant Customer | Accounts Receivable | Customer Concentration Risk    
Segment Reporting Information [Line Items]    
Concentration risk (as percent) 14.00% 11.00%
Two Customers | Accounts Receivable | Customer Concentration Risk    
Segment Reporting Information [Line Items]    
Concentration risk (as percent) 11.00% 11.00%
v3.22.4
Segment Information - Reportable Segments (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 29, 2023
Jan. 30, 2022
Jan. 31, 2021
Segment Reporting Information [Line Items]      
Revenue $ 26,974 $ 26,914 $ 16,675
Operating income (loss) 4,224 10,041 4,532
All Other      
Segment Reporting Information [Line Items]      
Revenue 0 0 0
Operating income (loss) (5,411) (3,049) (2,628)
Graphics | Operating segments      
Segment Reporting Information [Line Items]      
Revenue 11,906 15,868 9,834
Operating income (loss) 4,552 8,492 4,612
Compute & Networking | Operating segments      
Segment Reporting Information [Line Items]      
Revenue 15,068 11,046 6,841
Operating income (loss) $ 5,083 $ 4,598 $ 2,548
v3.22.4
Segment Information - Reconciling Items (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 29, 2023
Jan. 30, 2022
Jan. 31, 2021
Segment Reporting Information [Line Items]      
Stock-based compensation expense $ (2,709) $ (2,004) $ (1,397)
Income from operations 4,224 10,041 4,532
All Other      
Segment Reporting Information [Line Items]      
Stock-based compensation expense (2,710) (2,004) (1,397)
Acquisition termination cost (1,353) 0 0
Acquisition-related and other costs (674) (636) (836)
Unallocated cost of revenue and operating expenses (595) (399) (357)
Restructuring costs and other (54) 0 0
IP-related and legal settlement costs (23) (10) (38)
Contributions (2) 0 0
Income from operations $ (5,411) $ (3,049) $ (2,628)
v3.22.4
Segment Information - Revenue and Long-lived Assets by Region (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 29, 2023
Jan. 30, 2022
Jan. 31, 2021
Revenues and Long-Lived Assets      
Revenue $ 26,974 $ 26,914 $ 16,675
Long-lived assets 3,807 2,778  
United States      
Revenues and Long-Lived Assets      
Revenue 8,292 4,349 3,214
Long-lived assets 2,587 2,023  
Taiwan      
Revenues and Long-Lived Assets      
Revenue 6,986 8,544 4,531
Long-lived assets 702 379  
China (including Hong Kong)      
Revenues and Long-Lived Assets      
Revenue 5,785 7,111 3,886
Israel      
Revenues and Long-Lived Assets      
Long-lived assets 283 185  
Other countries      
Revenues and Long-Lived Assets      
Revenue 5,911 6,910 $ 5,044
Long-lived assets $ 235 $ 191  
v3.22.4
Segment Information - Schedule of Revenue by Market (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 29, 2023
Jan. 30, 2022
Jan. 31, 2021
Revenue from External Customer [Line Items]      
Revenue $ 26,974 $ 26,914 $ 16,675
Data Center      
Revenue from External Customer [Line Items]      
Revenue 15,005 10,613 6,696
Gaming      
Revenue from External Customer [Line Items]      
Revenue 9,067 12,462 7,759
Professional Visualization      
Revenue from External Customer [Line Items]      
Revenue 1,544 2,111 1,053
Automotive      
Revenue from External Customer [Line Items]      
Revenue 903 566 536
OEM & Other      
Revenue from External Customer [Line Items]      
Revenue $ 455 $ 1,162 $ 631
v3.22.4
Schedule II - Valuation and Qualifying Accounts (Details) - USD ($)
$ in Millions
12 Months Ended
Jan. 29, 2023
Jan. 30, 2022
Jan. 31, 2021
Allowance for doubtful accounts      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Period $ 4 $ 4 $ 2
Additions 0 0 2
Deductions 0 0 0
Balance at End of Period 4 4 4
Sales return allowance      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Period 13 17 9
Additions 104 19 30
Deductions (91) (23) (22)
Balance at End of Period 26 13 17
Deferred tax valuation allowance      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Period 907 728 621
Additions 577 179 107
Deductions 0 0 0
Balance at End of Period $ 1,484 $ 907 $ 728